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Long non-coding RNAs (lncRNAs) are increasingly recognized as important regulators of 
genomic processes and cellular specification.  Many lncRNAs regulate chromatin by functionally 
impacting the epigenetic state through direct interactions with chromatin-modifying proteins. We 
developed a protocol to enrich for chromatin-lncRNA interactions and used this technique to 
identify several candidate lncRNAs that interact with the Polycomb group (PcG) proteins.  Our 
immunoprecipitation protocol uses a crosslinked chromatin fraction as the input and employs 
stringent washes and cross-validation techniques to dramatically decrease mRNA signal (as a 
metric of transient interactions or false positives), and increase the dynamic range of conventional 
RNA immunoprecipitation protocols. Applying this protocol to the PRC1 component Bmi1, we have 
identified 11 PcG-interacting lncRNA candidates whose expression impacts the transcription of 
many other chromatin factors and PcG targets.  We focus on knockdown of one lncRNA 
candidate, CAT7, which increases expression of several homeobox-containing transcription factors 
as well as chromatin interacting proteins, including Trithorax group proteins, Jumanji-domain 
containing proteins, and PcG-like proteins in HeLa cells.  Consistent with the observed increase in 
gene expression, knockdown of CAT7 decreases PcG binding (Suz12, H3K27me3 and Bmi1) at 
the promoter of the homeodomain protein Mnx1, located at the boundary of an adjacent gene 
desert.  During early motor neuron differentiation from embryonic stem cells, knockdown of CAT7 
is accompanied by changes in expression of master regulators of neuronal specification: increased 
upregulation Mnx1, upregulation of Isl1, and downregulation of Irx3, as well as changes in 
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expression to several other PcG-regulated targets.  Overall, this protocol is the first of its kind to 
efficiently identify de novo interactions between the PcG proteins and lncRNAs which impact PcG 
binding or PcG target gene expression.
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Polycomb-Group Proteins and Long Non-Coding RNAs Contribute to Epigenetic 
Control of Transcription and Cellular Identity  
1
Cellular specification is an intricate process that involves many layers of genomic regulation. 
Transcription, as the direct output of the genome, is the foundation for establishing cellular 
identity.  The contribution of transcription to cellular identity is evidenced by the diverse spectrum 
of RNAs present in any given cell type 1-3, including transcripts originating from both protein-
coding and non-coding regions of the genome.   However, transcriptional diversity cannot arise 
from the DNA sequence alone, since, from fertilization onwards, nearly every cell in the body 
contains essentially the same DNA.  Regulation of when, where, and how much of a gene is 
transcribed must then, in part, be “epigenetic”: independent of DNA sequence, easily modified, 
and heritable through cell division.  Here, I review protein-based modes of epigenetic inheritance 
and also explore the role of non-protein coding transcripts in directing these processes. 
 
Epigenetics 
While genetic information is a means to retain information from our parents, epigenetic control 
allows the body to alter its usage of that information in response to the environment.  In this way, 
environmental cues (such as diet, development or disease) can leave a molecular impression to 
impact gene expression, even after the environment has changed. 
Epigenetic control of transcription involves several layers of regulation.  As one means of 
epigenetic control, the genome is organized into repeated units of DNA spooled around a core 
set of proteins called the histone proteins.  The regular inclusion of histone proteins throughout the 
DNA provides a ubiquitous platform for an additional layer of genomic regulation. The placement 
of histones on the DNA, the higher order organization of the histones in the nucleus, and physical 
modification of the histones or the DNA itself, can epigenetically influence gene expression. 
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Histones are present in eukaryotes and Achaea, and are the most highly conserved of all proteins.   
The vertebrate somatic histones (H2A, H2B, H3, and H4, or their variants) form heterodimers that 
together compose an octameric core, around which a nearly equivalent mass of DNA (146 
basepairs) is wrapped; this structure is called the nucleosome.  Small stretches of linker DNA 
between nucleosomes are associated with the histone protein H1 in some silenced regions of the 
DNA.  The nucleosome is itself the fundamental repeated unit of a more highly ordered structure, 
chromatin, which also includes tethered proteins and RNAs.  Finally, chromatin is further arranged 
in the 3D space of the nucleus, having a highly regulated, but still fluid conformation.  In effect, 
organizing the genome into chromatin not only provides a platform for regulation, but protects the 
DNA from damage and condenses it to fit in the nucleus.   
Chromatin organization also influences molecular processes, such as transcriptional initiation and 
elongation 4-6, which require direct interaction of protein complexes with the DNA.  Specifically, 
binding of the transcription factor TBP to the DNA upstream of the transcription start site (TSS) is 
required for transcriptional initiation by RNA Polymerase II.  Nucleosomal depletion at the TSS, 
which is a hallmark of active eukaryotic genes, permits direct access of TBP to the DNA so that the 
pre-initiation complex may assemble 7-9.  Conversely, the presence of a nucleosome occluding the 
TSS is often a feature of silenced genes 10,11. For example, studies in mouse tissue report that a 
wide array of liver-specific genes, such as Cytochrome P450 and Murinoglobin1, display “on” 
(depleted TSS) or “off” (occluded TSS) modes of nucleosomal occupancy in matched liver and 
brain samples, respectively12.  Similarly to the TSS, other regulatory regions that are bound by 
transcription factors may also differ in nucleosomal occupancy to influence tissue specific “on” 
versus “off” states 13.  Such loci may include sites adjacent to the TSS, called promoters, or distal 
sites, called enhancers.  During hematopoiesis, the collinearly regulated globin genes display 
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coordinated changes in nucleosomal occupancy at both individual promoters and at a shared 
enhancer site14,15. 
The rate of proper transcriptional elongation can also be influenced by “remodeling” the 
nucleosomes: sliding a nucleosome along the DNA, sterically altering the DNA/histone interactions, 
or subjecting the nucleosome to histone replacement or ejection 6,8.   In vitro transcription of 
nucleosomal arrays reveals that the presence of a nucleosome greatly slows the rate of 
transcription, as compared to naked DNA 16.  During elongation of highly transcribed genes, such 
as Hsp70 in heat shock response, entire histone octamers may be rapidly ejected from the gene 
body to facilitate immediate access of the large (1 MegaDalton) RNA polymerase to the DNA 17. 
However, only one histone pair (H2A/H2B) is ejected during elongation of moderately 
transcribed genes.  This topologically limits the rate of elongation because the polymerase must 
travel along the DNA that is partially constrained by the remaining histones18-20.  Inclusion of 
specific histone variants, such as H3.3 in the gene body or H2A.Z at the -1 nucleosome, is also 
correlated with active transcription 21. 
Many remodeling events, such as those as above, require breaking hundreds of points of contact 
between the DNA and the histones, and overcoming biases for nucleosome positioning which may 
be driven by DNA sequence 22.  These processes may be carried out in an ATP-dependent 
manner, as an active means of transcriptional regulation 8,9,23.  Mutations in ATP-dependent 
chromatin remodelers display an expansive range of effects, such as global misregulation of 
splicing 24, or widespread developmental effects, as in CHARGE syndrome 25. 
Physical epigenetic marks on the chromatin comprise another form of epigenetic regulation.  Such 
marks consist of either methylation of the DNA itself at CG dinucleotides (“CpG”) or covalent 
post-translational modifications, including methylation or acetylation (among others), of the N-
terminal tails of histones26.  Histone N-termini are structurally disordered and protrude from the 
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core of the nucleosome, allowing access to enzymes or transcription factors that can modify or 
recognize specific histone residues.  These modifications alter the sterics of DNA/histone 
interactions, the stacking or compaction of nucleosomes, and the binding of non-histone proteins to 
the chromatin 6.  Consequently, histone marks are correlated with and, in some instances, are 
necessary for, altered levels of gene expression 27-29.  
Histone marks, as well as the incorporation of histone variants, are believed to have combinatorial 
effects on both small regions of the genome, such as promoters, as well as large “domains” of 
chromatin. One broadly defined domain, heterochromatin, was first described as the regions of 
the nucleus that exhibited intense staining by the intercalating dye DAPI.  Heterochromatin 
corresponds to transcriptionally silenced, gene-poor regions of DNA, in contrast to its gene-rich, 
transcriptionally active counterpart, euchromatin.  On the molecular level, heterochromatin is 
characterized by highly compacted nucleosomes, and the presence of the H3K9me3 mark of 
silencing, the transcription factor HP1 and the linker histone H1 30.  Euchromatin is generally less 
compacted, though not all parts of euchromatin are actively transcribed, and not all 
heterochromatin is strictly silent. 
Chromatin may also be classified into domains in both a functional manner: displaying 
interdependent levels of gene expression, and/or a physical manner: co-localizing in 3D 
space31,32.  Such domains may be comprised of segments of DNA that are not necessarily 
contiguous. While the precise mechanisms for establishing or maintaining chromatin structure are 
not well understood, these processes are largely modulated by DNA sequence, transcription 
factor binding, and chromatin remodeling. 
The organization of chromatin into physical domains is a pervasive mechanism for transcriptional 
regulation.  Domains of “active” or “silenced” chromatin can extend in physical space to impact 
expression of seemingly unrelated, but proximal genes.  In flies, an inverted translocation of the X 
5
chromosome causes the pigment gene white to be adjacent to heterochromatin. The result is a 
variegated change in eye color in males: though genetically identical, only a portion of the mutant 
cells show a null (colorless) phenotype, caused by variable spreading of heterochromatin to 
silence the white gene 33,34. This quintessential example highlights the profound influence of 
nuclear architecture and epigenetic boundaries on gene expression. 
Similarly, in wild-type cells, broad euchromatic domains are further subdivided and modularly 
regulated.  For example, a group of developmental proteins called the HOX genes are 
organized co-linearly on the chromosome.  Spatially and temporally coordinated expression (or 
silencing) of HOX genes is essential for proper body patterning during development.  The active 
and silenced domains are often segregated from each other by insulator proteins, such as the 
architectural, sequence-specific DNA binding protein, CTCF.  Upon perturbation of the binding site 
for CTCF between active HOX genes and a silenced enhancer, the organism can no longer silence 
the enhancer region, leading to aberrant expression of HOX genes and developmental defects 
35. This example shows the relevance of chromatin organization and boundaries to gene 
expression. 
An important aspect of epigenetic inheritance is stability through cell division.  For a cell to divide, 
the DNA must be replicated and then split evenly into each daughter cell.  During DNA 
replication, chromatin is dismantled, and most proteins (including histones) and RNAs are stripped 
from the DNA to allow access to the replication machinery 36.  Upon completion of replication and 
subsequent cell division, each cell must re-establish its former nuclear architecture to maintain 
cellular identity.  Rather than initiating this process de novo with respect to each cell type, the cell 
employs a mechanism to “remember” the former epigenetic state.  While this process is poorly 
understood, it is known that a small portion of certain transcription factors remain bound to the 
DNA, demarcating the epigenetic features and boundaries which underlie a cell’s identity37,38.  
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The process of establishing chromatin architecture from such boundaries is also unknown, but is 
influenced by spreading of genomic features within the retained boundaries and preservation of 
DNA methylation on the parent strand.    
Dividing cells (such as stem cells) have both the ability to self-renew and to develop into 
terminally differentiated cells.  A stem cell not only expresses many different genes compared to 
a terminally differentiated cell, but also differs in its epigenetic signatures and chromatin 
architecture across much of the genome3.  A stem cell may divide and then alter its epigenetic 
state in order to differentiate, or it may maintain its epigenetic state to remain a stem cell 39.  In 
this way, maintenance of epigenetic marks and chromatin domains is critical to both establishing 
and preserving cellular identity, and is a defining characteristic of epigenetic inheritance.  
While the importance of epigenetic regulation is apparent from its impact on genomic regulation 
and a number of disease states, many aspects of epigenetic regulation remain unknown.  A major 
question is how epigenetic regulators coordinate with each other to execute targeted changes to 
transcription, and how chromatin is regulated in response to various biological stimuli or through 
biological processes, such as differentiation, cell division, and cancer. 
   
The Polycomb Group Proteins 
The Polycomb group (PcG) proteins are a prominent group of transcription-modulating proteins 
important for epigenetic maintenance of gene silencing.  Polycomb was first defined as a 
dominant genetic mutation in flies causing aberrant expression of the gene Scr, resulting in the 
formation of extra pairs of sex combs on the second and third legs of male flies40,41. Further 
genetic and biochemical investigation showed that Polycomb, in complexes with a handful of other 
proteins collectively termed the PcG proteins, is critical for proper gene silencing of the axial 
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development proteins, the HOX genes.  Not all trancriptionally inactive genes are silenced by 
PcG proteins; rather, PcG target genes are heavily enriched for developmental regulators42,43.   
Since their initial discovery, PcG proteins and their homologs have been identified throughout 
metazoans, regulating thousands of genomic targets in every cell type and playing critical roles in 
cancer, cell cycle, and most notably in embryonic development.    
In mammals, PcG proteins are critical for regulating cell plasticity by silencing certain 
developmental factors so that others may activate properly.  Remarkably, cells are unable to 
progress from the embryonic stem (ES) cell state without the PcG proteins, and will die upon 
differentiation 44,45. In addition, many multipotent stem cells show accelerated differentiation upon 
PcG depletion 46.  PcG proteins may also play a role in maintaining the state of terminally 
differentiated cells.  Ablation of PcG proteins in adult mouse neurons (via a conditional knockout) 
leads to progressive neurodegeneration, memory loss, and impaired mobility, a phenotype similar 
to Huntington’s Disease 47.  These changes have been previously associated with derepression of 
homeobox-domain containing genes and developmental transcription factors, the characteristic 
targets of PcG proteins.  
Mechanistic studies have shown that PcG proteins maintain transcriptional silencing in an 
epigenetic fashion; they modify chromatin architecture by compaction of polynucleosomes and 
covalent modification of histones. There are at least two major functional core complexes of PcG 
proteins: PRC1 and PRC2, though many subcomplexes are still being identified and functionally 
defined 48.  Broadly, PRC2 has histone-methyltransferase activity, conferring tri-methylation of 
lysine 27 of H3 (H3K27me3) as a mark of silenced euchromatin. PRC1 has a binding preference 
for H3K27me3 nucleosomes 49 and is recruited to many (but not all) of the same sites as PRC2, 
possibly through an independent recruitment mechanism 42,50,51.  H3K27me3 is not necessary for 
all PcG-mediated silencing.  In fact, PRC1 binding is sufficient for compaction of polynucleosomes 
8
in vitro 52,53 , and correlates with gene silencing in vivo.  A specific subcomplex of PRC1, 
potentially exclusive from the compaction complex, also ubiquitinates histone H2A at lysine 11954.  
However, the significance of this mark to silencing in mammals is unknown.    While the core 
proteins of PRC1 and PRC2 are conserved between flies and mammals, notable differences in the 
catalytic activity of each component 52 and in PcG recruitment exist between the two species. 
In both mammals and flies, PcG proteins form “bodies” or large 3D structures composed non-
contiguous regions of the chromatin whose silencing is interdependent55.  While the formation of 
PcG bodies is not well understood, fly PcG bound loci are proposed to scan the nucleus in trans 
for similarly bound sites, creating PcG bodies.  PcG repression in cis is partially explained in flies 
by (non-PcG) transcription factor binding at PcG-target promoter regions.  Briefly, functionally 
defined stretches of DNA, called Polycomb Response Elements (PREs) dock the PcG proteins to 
cause silencing of the adjacent chromatin 56.  Fly PREs are non-uniformly marked by combinations 
of binding motifs of various sequence-specific transcription factors which together recruit PcG 
proteins.  However, in mammals, none of the sequence-specific transcription factors are conserved 
with the exception of Pho/YY1, whose binding is not sufficient to define a PRE.  Though the first 
mammalian PREs have recently been discovered 57,58, pinpointing additional mammalian PREs is 
further obfuscated by the broad regions (relative to regions in flies) of PcG binding and 
H3K27me3.  This difference highlights the possibility of distinct mechanisms between the species in 
recruitment or spreading of PcG proteins.  
Targeting of mammalian PcG complexes remains elusive, and different modes of targeting may 
exist in different biological contexts.  In ES cells, PRC1 and PRC2 complexes bind almost 
exclusively to unmethylated CpG dinucelotides and primarily target developmental 
regulators39,59.  As development progresses, PcG repression is selectively lost at specific 
developmental genes in order to facilitate differentiation of the cell down a defined lineage 
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pathway.  As seen during differentiation of insulin-producing beta cells60, canonical PcG signaling 
may govern the transcriptional state.  An array of classical PcG-regulated, CpG-rich, 
developmental targets become derepressed from the progenitor state, losing H3K27me3 as the 
beta cells mature.  These targets are essential master regulators of both beta cell and neuronal 
differentiation, and strongly influence the transcriptionally circuitry.  In fact, though beta cells and 
neurons originate from different tissues (endoderm versus ectoderm) which diverge at the earliest 
stages of development, the transcriptome of beta cells is more similar to neuronal cells than to 
other endoderm-derived tissues 60.  This process is reflective of the essential role of the PcG 
proteins in development and cellular specification. 
Concurrently, during beta cell differentiation, PRC2 mediated silencing (at least as evidenced by 
H3K27me3 signatures) also occurs de novo at genes which are not canonical PcG targets.  Beta 
cell progenitors express several non-developmental proteins, such as SLC16A1 (insulin 
hypersecretion/monocarboxylic acid transport), that impede differentiation or survival of beta 
cells.  However, these genes are transcriptionally silent and are enriched for H3K27me3 in mature 
beta cells60.  Unlike the canonical PcG targets, these de novo silenced genes are not enriched for 
CpG islands, and are not silenced by H3K27me3/PcG proteins in ES cells, other tissues, or at 
earlier developmental stages.  Together, these data reveal the complex nature of mammalian 
PcG regulation. 
The targeting of PcG proteins at regions transitioning from silent to active (or the reverse) is not 
well understood.  A class of activating proteins called the Trithorax group proteins (TrX) 
functionally antagonize the PcG proteins, binding at many of the same sites, but conferring a 
mark of initiation (H3K4me3) at promoters.  Genes which contain both H3K4me3 and H3K27me3 
at their promoters (e.g. bivalent domains) are considered to be in a transitory chromatin state, 
where they are poised for activation or may already be transcribed.  Importantly, there are 
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several H3K4me3 histone methyl-transferases, but to date, PRC2, and specifically, its core 
component EZH2 (or occasionally, the closely related EZH1), are the only known H3K27me3 
methyltransferases in vivo.   
Several studies have also implicated a class of tudor-domain containing proteins in the transition 
from an active to a PcG-repressed state 61.  These proteins bind specifically to marks of active 
chromatin, such as H3K36me3 or H3K4me3, and form complexes with histone demethylases.  
Removal of such marks may allow the PRC2 proteins to bind and confer the H3K27me3 mark.  
Additionally, binding partners of PRC2, such as the inactive histone demethylase Jarid2, may also 
contribute to its binding specificity 48.  In one model of PcG regulation, PRC2 samples the genome 
to identify nucleosome-dense 62, primed chromatin and/or a lack of mRNA transcription 63,64, 
before stably binding.  PRC1 binding may follow PRC2 binding, though is generally considered a 
form of more stable silencing and might employ independent recruitment mechanisms. 
This model is nevertheless unsatisfying: protein-based mechanisms are often correlative, and 
currently are too broad to explain the complex mechanisms precisely governing PcG activity. 
Historically, proteins, such as the PcG proteins and their binding partners, were considered the 
readers, writers and erasers of epigenetic marks.  However, recent evidence potentiates another, 
rapidly generated, class of epigenetic effectors that may modulate activity of protein complexes: 
namely, RNA molecules which are never translated into protein (ncRNAs).  Specifically, these 
molecules have been shown to interact with PcG proteins in the nucleus, and are proposed to play 





Long non-coding RNAs 
Non-coding RNAs (ncRNAs) are increasingly recognized as regulators of cellular specification and 
many biological processes.  Their contribution to transcriptional diversity is astounding: while at 
least 80% of the genome is transcribed, less than 2% of the genome is translated into protein 1.  
The significance of the non-coding transcriptome to life is perhaps best exemplified by staggering 
developmental defects or lethality induced by depletion of any one of a multitude of ncRNAs, 
several of which will be reviewed below.  However, identification of functional ncRNAs and the 
mechanisms of how ncRNAs execute their functions in the cell are widely unknown.   
Many ncRNAs function in protein complexes, acting in capacities often ascribed to protein 
components: sequestering proteins from other targets, allosterically regulating protein binding 
domains, targeting proteins to the DNA or mRNA, or acting as scaffolding for protein 
complexes65.  The mechanisms underlying these protein/ncRNA interactions often necessitate strict 
sequence motifs, length, or structural features in the ncRNAs, such as are found in ribosomal RNAs, 
transfer RNAs and short RNAs (siRNAs/piRNAs/miRNAs/snoRNAs /snRNAs). 
Most ncRNA species, however, do not fall into these well-established classes and their function, 
structural motifs, and protein binding partners, if any, are not well defined.  Amidst this ambiguity, 
a very broad classification of long ncRNAs (lncRNAs) has emerged in recent years.  These lncRNAs 
annotations are usually derived from deep transcriptome sequencing data (RNAseq) from a 
variety of tissues or cancers, with a focus on intergenic, intronic or long antisense transcripts with 
low coding potential 2,66,67.  Typically, lncRNAs are over 200 basepairs in length, spliced, 
expressed at lower copy number per cell compared to mRNAs (with some exceptions), and 
frequently display cell-type specific expression.   Lists of putative lncRNAs have also been 
bioinformatically curated based on the genomic features of actively transcribed chromatin at 
protein coding RNAs (mRNAs) and a few known lncRNAs.  These predictions preferentially 
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consider regions of the genome with chromatin marks of initiation and elongation (H3K4me3 and 
H3K36me3 respectively), RNA polymerase II binding, capping and polyadenylation.  
Additionally, some predictions rely heavily on conservation: based on the idea that functional 
lncRNAs will have sequence-based or syntenic conservation, and supported by the observation 
that many lncRNAs are transcribed from pseudogenes 66.  Conversely, other predictions contend 
that because lncRNAs are largely repetitive and do not code for amino acids, they are 
hypoconserved (compared to protein-coding genes) with the exception of small stretches of 
evolutionarily pressured interaction domains 67.  
LncRNAs have been implicated in cancer, development, sex determination and various diseases in 
the body.  Knockout of the canonical lncRNA Xist, is embryonic lethal in female mammals, as 
developing female cells lacking Xist cannot balance expression of RNA from both X-chromosomes 
68.  Similarly, depletion of the lncRNAs Fendrr and Braveheart cause embryonic-lethal defects in 
murine heart formation 69,70, and depletion of HOTTIP 71can induce limb malformations.  In 
zebrafish development, the lncRNAs Cyrano and Megamind lead to widespread developmental 
defects: notochord and Neurod-related defects, and brain/eye malformations, respectively 67.  
Surprisingly, morpholino depletion of Cyrano and Megamind can be partially rescued by ectopic 
expression of the syntenic human transcripts.  The syntenic transcripts are not well conserved with 
respect to sequence, with the exception of small, putative protein binding domains.  A plethora of 
other lncRNAs has also been correlated with cancer prognoses and congenital diseases such as 
Brachydactyly 72, and many lncRNAs show overexpression in specific tissues or diseases in vivo 73.  
However, understanding the mechanisms of these lncRNAs remains technically challenging. 
While lncRNAs have been implicated in countless biological processes, there is almost no 
understanding of which features make a lncRNA biologically relevant 74.  On the contrary, there 
are some cases where lncRNA depletion has no apparent effect on the cell 75.  Rather, the 
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opening of the chromatin through the process of transcription might be necessary for gene 
regulation of certain loci, rather than the transcript itself.  Alternatively, a transcript may simply 
be a byproduct of open chromatin, where spurious promoters become accessible.   Notably, 
spurious, mis-spliced, or abortive transcripts, as well as introns of highly transcribed genes, often 
have very short half lives in the cell 76,77.  This indicates that there might be specific characteristics 
to mark which transcripts are retained.  Furthermore, it is not known if and how lncRNAs avoid 
translation, particularly because a number of lncRNAs were identified because they have similar 
features or genomic signatures as mRNAs (such as polyA tails).  Features such as secondary 
structure, length of the polyA tail (if any) or association with a specific ribosomal protein 78 or 
snRNA 79 may control RNA stability or translational potential, though several of these hypotheses 
remain speculative or disconnected from true causation.  Such inquiries will be difficult to ascertain 
until the lncRNAs are more conclusively annotated and classified. 
Many lncRNAs, such as Xist, HOTTIP, Braveheart or Fenderr, have been shown to execute their 
widespread functions by modulating transcription through direct interactions with chromatin 
proteins.  lncRNAs are involved in a broad scope of chromatin processes, affecting expression of 
both specific loci and entire chromosomes, and organizing the formation of nuclear structures or 
domains.  Xist interacts directly with the X chromosome in female cells, silencing the entire 
chromosome from which it is transcribed.  Xist initially localizes to gene-rich regions on the 
chromatin in a seemingly sequence-independent, proximity-driven manner 80,81.  Namely, it binds 
to gene-rich regions proximal in 3-D space to its transcription site, and spreads to coat and 
silence nearly the entire X-chromosome.  Antisense-blocking of the RepC region of Xist prevents 
Xist from nucleating, and therefore stops spreading of Xist and inactivation of the X chromosome.  
This phenotype is relieved as the blocking-oligo is diluted through cell division.  
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lncRNAs have also evolved to regulate the expression of individual loci by interaction with the 
chromatin 65.  Some genes, such as the imprinted genes, require that only one allele is transcribed.  
However, unlike the X chromosome, which is inactivated at random early in development, the 
expression of the imprinted genes is determined by parental origin: DNA methylation of imprinted 
enhancer elements persists through gametogenesis to control gene expression in the progeny.  
lncRNA transcripts have been isolated from many imprinted genes, including the Kcnq1ot182, 
Gtl283, Airn 84, and h19 32 lncRNAs, and are necessary for silencing of the Kcnq1, Dlk1,  Igf2r, 
and Igf2 loci, respectively.  An exception is h19 which is thought to be transcribed from an 
enhancer region, but whose expression impacts silencing of several distal regions. Generally, 
imprinted lncRNAs colocalize with the chromatin, may or may not be involved in antisense 
regulation, and are necessary for silencing of large (often >100kb), contiguous segments of the 
DNA.   
Another class of lncRNAs is a cis acting antisense-derived lncRNAs.  Two such lncRNAs, ANRIL 85 
and Evf2 86, act as a switch to determine which gene is expressed from a co-regulated locus.  
These lncRNAs may function by recruiting silencing (or activating) factors cotranscriptionally: 
ANRIL balances the expression of InK4A and Arf to regulate cell cycle and senescence, and Evf2 
regulates the homeotic Dlx5/6 locus in neural development.  In both instances, the lncRNAs contain 
sequence that is antisense to the mRNA in the respective loci, but also contain regions necessary to 
recruit chromatin proteins.  In comparison to imprinted loci, antisense regulated genes silence much 
smaller genomic regions, indicating potential differences in recruitment and/or spreading 
mechanisms.   
Establishment of nuclear domains or structures may also be dependent on lncRNAs. Telomeric 
silencing and some instances of heterochromatin formation have been shown to be dependent on 
lncRNAs87,88, as has the formation of nuclear paraspeckles via the highly abundant lncRNA, 
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NEAT189.  Additionally, the HOX-locus encoded transcript HOTTIP influences HOX genes up to 
nearly 40 kb away, but physically near HOTTIP in 3D space71.  Proximity to HOTTIP RNA has 
been shown as necessary and sufficient to organize long range interactions and specifically 
impact gene expression.  Finally, knockdown, knockout and DNA-FISH studies implicate Kcnq1ot1 
in control of the expression and chromatin architecture of the ~1 Mb Kcnq1 locus82,90-93.  
Transgenic expression of Kcnq1ot1 is sufficient to bidirectionally silence flanking genes in vivo82.  
Kcnq1ot1 also organizes chromatin so that its targets are in proximity of silenced genes to 
perinucleolar regions, presumably to facilitate silencing91.  Mechanistically, Kcnq1ot1 has been 
proposed to act like Xist, to concurrently mediate gene expression and chromatin 
architecture90,91,93. 
 
Relationship between PcG proteins and lncRNAs 
As has been seen in plants, several lncRNAs have been shown to directly contribute to PcG 
recruitment or silencing in mammals.  Among these lncRNAs are Xist (PRC2) 94, Braveheart 
(PRC2)70, the HOX encoded transcript HOTAIR (PRC2) 95, Fendrr (PRC2) 69, Kcnq1ot1 (PRC2) 82, 
Gtl2 (PRC2) 83 and ANRIL (PRC1 and PRC2) 85,96, though notably, these genes are not conserved 
in flies, or even necessarily between mouse and human.  Depletion of these lncRNAs culminates a 
loss of silencing of the respective target loci (ref) and/or death.   
Direct interactions of lncRNAs and the PcG proteins were primarily found through a protocol 
called RNA immunoprecipitation (RIP) or the closely related UV-crosslinked RIP (CLIP), where 
lncRNAs are pulled down via a protein interactor 97.  Several of the above studies have been 
supplemented by gel shift/EMSA (electric mobility shift assays), or by studies where PcG proteins 
bind to ectopic lncRNAs in nuclear lysate.  However, such assays must be revisited, as recent 
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evidence suggests that the PRC2 protein, EZH2, binding strongly to RNAs without clear sequence 
specificity in vivo and in vitro 54,64.  Additional evidence to support these interactions comes from 
perturbation data, showing knockdown of a candidate impacts transcription of PcG target genes 
and PcG localization to target loci, such as for Braveheart, HOTAIR, or Gtl2.  Similarly, both Alu-
repeat deletion and competitive blocking interactions of the ANRIL transcript 49,98, where 
complementary oligos hybridized to ANRIL at putative PcG/RNA-binding sites, yield changes in 
gene expression and loss of PcG binding to the RNA and the regulated Ink4a/Arf DNA locus .  
Complementary mutations to PcG proteins (CBX7) showed a similar result.  Finally, RNA and DNA 
FISH data reveal that in the absence of the PRC2 (e.g. Eed knockout), several genes in the Kcnq1 
locus lose their silencing 91.   
Perhaps the most extensive mechanistic studies on lncRNA/PcG interactions validate interactions 
between the PcG proteins and Xist.  In a set of experiments, Xist was specifically pulled down via 
antisense oligos, alongside its associated chromatin 80,81.  These studies showed that PRC2 is 
recruited to the X chromosome in direct proportion to Xist binding, consistent with the hypothesis 
that Xist mediates PRC2 binding along the inactive X.  EMSA and deletion analysis have also 
implicated the A-rich repeat RepA of Xist, as a region of PcG interaction 94.  RepA is essential for 
silencing and spatial organization of genes on the inactive X chromosome.  Mutation or deletion of 
RepA leads to a loss of the Xist/EZH2 binding in vitro, and a loss of Xist binding and silencing at 
genic regions along the X-chromosome in vivo.  
Finally, the PcG proteins have been shown to interact with components of the RNAi machinery and 
the RNA helicase, MOV10 99.  Perturbation of MOV10 causes imbalances in INK4a/Arf 
expression, and is speculated to directly impact ANRIL functionality.  Together, these data suggest 
a versatile relationship between many lncRNAs and the PcG proteins in gene silencing. 
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In addition to lncRNAs that bind to the PcG proteins, short (50-200nt) double-hairpin ncRNAs also 
are also transcribed from binding sites of PRC1 and PRC2 proteins, and bind the PRC2 protein 
Suz12 as assessed by RIP and EMSA 100.  These short ncRNAs are transcribed from sites of CpG 
rich regions at the 5’ end of many PcG targets, and are often accompanied by paused RNA 
Polymerase II.  The hairpins are thought to work upstream of PcG silencing, and might serve to 
fine-tune PcG proteins by recruiting them to target gene promoters, or to act as scaffolding for 
complex assembly. 
Many intergenic regions which show changes in PcG binding during development are also 
transcribed 101. The genomic boundaries of such lncRNA transcripts precisely coincide with 
conserved regions of Suz12 binding and/or H3K27me3 (at some developmental point), though 
the transcribed regions are often CpG-poor.  Expression of these lncRNAs may either coincide 
with or oppose PcG binding and H3K27me3.  Knockdown of several such lncRNA transcripts 
generated from PcG sites affects transcription of both flanking (cis) and distant (trans) PcG 
regulated genes (ref) in differentiating mouse neural precursor cells.   Though a direct interaction 
of these lncRNA transcripts with the PcG proteins has not been thoroughly investigated, these data 
support the role of ncRNAs as major players in the transcriptional circuitry, particularly at PcG-
regulated genes essential for embryonic development. 
While many PcG interacting lncRNAs, such as Xist and Kcnq1ot1, are proposed to modify 
chromatin structure over long ranges in cis, the first candidate trans acting lncRNA has also been 
identified: the HOX encoded transcript, HOTAIR 95.   Expression of HOTAIR is important for PcG 
mediated silencing of a HOX gene on an entirely different chromosome.  However, the low-
expression of lncRNAs, such as HOTAIR or HOTTIP, raises mechanistic questions of how lncRNAs 
could locate their genomic targets in the nucleus.   
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The possibility of lncRNAs organized with both distant and nearby chromatin, such as is the case 
for the (highly expressed) NEAT1-dependent formation of paraspeckles 89, provides an attractive 
mechanistic hypothesis that could support the existence of trans-acting, low abundance lncRNAs.  
In the context of PcG proteins, lncRNAs might bind PcG proteins as they sample the genome, and 
tether, scaffold or recruit the PcG proteins to PcG bodies and trans loci.  In this way, similar to Xist 
and Kcnq1ot1 activity in cis, even low-expression, trans acting lncRNAs could micro-organize PcG 
activity and chromatin structure. 
One lncRNA which controls expression in a colocalized region of the genome is the transcript from 
the CISTR-ACT locus 72.  This lncRNA is upregulated in patients exhibiting certain forms of 
Brachydactyly.  While the CISTR-ACT transcript has not been shown to interact directly with the 
PcG proteins, overexpression of the transcript causes changes in PcG-regulated genes which are 
spatially co-localized (both genes in trans and in cis) with CISTR-ACT.  This culminates in 
widespread changes in EZH2 binding and gene expression of developmental targets.   
Several individual PcG proteins have shown in vitro binding to RNAs through gel shifts.  The EZH2, 
EZH2 with EED, and Suz12 components of PRC2 have each shown binding to various RNAs.  
However, recent studies have demonstrated that EZH2 binds many RNAs in vitro and in vivo 
without strong sequence specificity 63,64. Notably, structural conservation is very difficult to predict, 
and was not well accounted for in these studies. 
While PRC2 binds promiscuously to RNAs around the genome, lncRNA function in the specific 
setting of PRC1-mediated stable silencing and/or compaction is relatively unexplored.  Several 
PRC1 proteins, such as the chromodomain of CBX7 49and the Phe-Cys-Ser (FCS) domain of 
Polyhomeotic 102, have shown RNA binding without sequence specificity in vitro.  Mutated FCS of 
Polyhomeotic in flies leads to lower levels of repression at an array of PcG targets in vivo. In the 
case of CBX7, the compaction subunit in mammalian PRC1, the chromodomain has shown both in 
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vitro binding to ssRNA, and to a lower extent dsRNA, as well as a minor affinity for dsDNA.    
Notably, the chromodomain also shows high affinity for H3K27me3 nucleosomes in vitro, and as 
suggested by immnoflourescence and ChIP studies, in vivo54,85,103.  Mutation of CBX7 leads to 
decreased binding and silencing of ANRIL in vitro and in vivo respectively49.  However, mutations 
to PcG proteins are often difficult to interpret as they effect wide-spread changes in the 
chromatin landscape.  An underlying question remains as to how the PcG proteins bind specifically 
to RNA in vivo. 
While there is an ever-growing body of literature suggesting interactions between lncRNAs and 
the PcG proteins, the precise nature of these interactions is relatively unknown.  Namely, 
mechanistic studies and identification of lncRNA interactors are hindered by the high incidence of 
non-specific binding between PcG proteins and RNA, a lack of understanding of how the protein 
complexes specifically recognize partner lncRNAs, and the uncertainty of which PcG directly bind 
RNA in vivo.  In my study, I developed a protocol that identifies novel, non-random lncRNA 
interactions with chromatin proteins, across a large range of transcript expression.  This protocol 
does not require knowledge of which PcG protein(s) directly bind the lncRNA, or are necessary 
for binding specificity.  By employing cross-validation and stringent washes, the protocol greatly 
reduces mRNA noise or transient interactions.  I used my protocol to find lncRNAs that bind the 
PcG proteins in the context of stable silencing by the PRC1 complex, and found that a majority of 
the candidates assayed show widespread changes to the PcG-regulated transcriptional gene 
network upon siRNA knockdown.  Finally, I also found that depletion of one candidate, CAT7, 
causes loss of PcG binding at the promoter of an upregulated gene Mnx1.  Lastly, I showed 
depletion of CAT7 also induces differential expression of several PcG-regulated master 
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Long non-coding RNAs (lncRNAs) are increasingly recognized as important regulators of genomic 
processes and cellular specification.  Many lncRNAs are hypothesized to regulate chromatin by 
functionally impacting the epigenetic state through interactions with chromatin-modifying proteins.  
Recently, numerous lncRNAs have been reported to play roles in the activity or recruitment of 
epigenetic factors such as the Polycomb group (PcG) proteins, to genomic sites.  However, 
identification and functional validation of chromatin-interacting RNAs are technically challenging 
with respect to distinguishing true RNA interactors from artifacts.  In order to identify new lncRNAs 
that interact with PcG-bound chromatin, we developed an immunoprecipitation protocol which 
dramatically decreases mRNA noise (as a metric of false positives), and increases the dynamic 
range of conventional RNA immunoprecipitation (RIP).  Namely, we purified chromatin away from 
free nucleic acids and free proteins, performed an immunoprecipitation on the chromatin, and 
applied stringent washes geared at both RNA and protein specificity.  We then applied this 
protocol to the PcG protein Bmi1 to generate a list of novel candidate lncRNAs interactors, 
including the functionally-elusive RepE region of Xist.  Analyzing these candidates, we found that 
PRC1 putatively binds a class of nuclearly localized lncRNAs that show tissue-specificity in the 





Interactions between lncRNAs and chromatin proteins, such as the PcG proteins, have been 
identified in vivo by a technique called RNA immunoprecipitation (RIP)1.  In canonical RIP and its 
variations, cells may or may not be lightly crosslinked by formaldehyde or UV light, and RNAs 
are co-precipitated with a protein and sequenced.  RIP conditions are generally optimized for 
protein/protein stability and specificity; however, these are precisely the conditions which 
promote non-specific RNA/RNA or RNA/protein interactions2,3.   Such artifacts arise upon nuclear 
shearing, when distal RNAs are brought together and hybridize to one another via small stretches 
of complementarity4.   In addition, the limited stringency of native washes, the inefficiency of UV 
crosslinking, and the low shearing resolution of most RIP protocols also contribute to a very low 
signal to noise ratio.  As evidenced by the disparity of candidate lncRNAs found between various 
sources of PcG RIP data 5-8, there is a lack of consensus between RIPs from different groups, 
coupled with a high contamination of mRNA exons: a metric of false positives in RIP of many 
chromatin proteins.   
RIP has been successfully used to verify lncRNA/protein interactions, which were suggested a 
priori by other sources of data.  As exemplified by the lncRNAs interacting with PcG proteins, such 
as the essential cardiogenesis lncRNA Braveheart 9 or the HOX gene-regulator lncRNA HOTAIR 10, 
differential expression and knockdown of the transcripts were first observed to cause changes in 
expression of classical PcG target genes, and then sought out in PcG-RIP.  Likewise, in the case of 
the highly abundant lncRNA Xist 11 or several lncRNAs associated with imprinted genes8,12,13,  PcG 
proteins were already known to be involved in silencing of the adjacent target regions.  In these 
instances, RIP was used to verify, rather than to first indicate, the interactions with the PcG 
proteins. 
31
The overwhelming false positive rate renders RIP ineffective as a means to identify protein/RNA 
interactions de novo, at least for lowly or moderately expressed RNAs.  RIP often cannot readily 
discern true signal from noise of higher-expressed RNAs (such as mRNAs), essentially limiting the 
dynamic range of RIP to highly or overexpressed lncRNAs.  Furthermore, since most lncRNAs are 
expressed at significantly lower levels than mRNAs14,15, many lncRNAs are well outside this 
dynamic range.   Indeed, RIP is not a robust technology for uncovering novel chromatin-interacting 
lncRNAs, and, a scarce number of RNAs from such studies have been biologically verified. 
The PcG proteins also pose particular biochemical challenges for finding novel lncRNA 
interactions.  Firstly, it is yet unclear which protein or set(s) of proteins directly bind to RNAs, or 
confer specificity for binding.  Previously, the PcG protein EZH2 had been shown in vitro to 
directly bind to RNAs such as the RepA region of Xist 11 and has since been shown to spread 
along the inactive X in correlation with Xist spreading 16,17.  However, recent evidence shows that 
EZH2 does not have strong specificity for any RNA motif, and strongly binds many RNAs 
regardless of sequence, in vivo and in vitro 2,18.  Additionally, EZH2 is just one of several proteins 
in the methyltranferase complex of the PcG proteins, PRC2.  It is not known whether the entire 
complex, or perhaps additional component(s) which interact with the complex, are important for 
proper lncRNA binding. 
PcG mediated silencing is also executed by another PcG complex, PRC1, whose interactions with 
lncRNAs are yet uncertain.  PRC1, or, more accurately, several PRC1-like complexes comprised of 
various combinations of subunits, are responsible for the compaction of chromatin and 
ubiquitylation of H2A.  It is this compaction which is thought to block access of the transcriptional 
machinery to the DNA.  PRC1 components are essential for the stabilization of silencing and are 
partially retained on the chromatin during mitosis to maintain epigenetic memory through cell 
division 19,20.  Though there is extensive overlap between PRC1 and PRC2 binding on the 
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chromatin21,22, differences in activity of the complexes, recruitment of the complexes, and binding 
sites exist23,24.  Therefore, it is mechanistically important to study lncRNAs in the presence of PRC1, 
the main engine of repression. 
Previous data have suggested interactions between PRC1 and lncRNAs25-27, though the specifics 
of such interactions remain unstudied.  It is not well understood if PRC1 directly interacts with RNA 
in vivo, or how lncRNAs impact the activity or recruitment of PRC1 to the chromatin.  Several PRC1 
components, such as Polyhomeotic show in vitro binding to RNA 27, though notably, many of those 
same protein domains bind DNA as well. The PRC1 proteins Bmi1 and CBX7 have been shown to 
interact with the lncRNA ANRIL 25,28 to modulate the Ink4a/Arf locus.  However, additional 
candidates have been poorly studied in comparison to PRC2-interacting lncRNAs.  It is not even 
known whether PRC1 is generally present at sites of lncRNA/PRC2 binding, or whether such 
interactions occur while PRC2 is bound to the chromatin.  We therefore sought to develop a 
method that was better able to predict novel lncRNA interactions with chromatin, and specifically 
to investigate lncRNAs present at sites of PRC1 binding. 
 
Results 
Our goal is to uncover novel lncRNAs that interact with chromatin, with the hypothesis that 
interacting RNAs may modulate gene expression.  While conventional RIP has been used to 
validate a priori hypotheses of lncRNA interactions, the variable results of such experiments 
between different groups, as well as strong mRNA contamination, indicate a high level of noise.  
Such noise interferes with identification of legitimate, stable lncRNA/chromatin interactions, and 
may arise from non-specific RNA interactions that occur during the purification, rather than in the 
cell.   
33
To this end, we attempted to improve the signal to noise ratio of conventional RIP by purifying 
chromatin as the input to the immunoprecipitation (IP), and tailoring the washes around both RNA 
and protein specificity.  Accordingly, we developed an IP protocol that uses a CsCl gradient to 
isolate chromatin, the substrate of the PcG proteins, away from free nucleic acids or free protein.  
We reasoned that by removing these sources of noise, we might also change the spectrum of 
RNAs that were pulled down to enrich for stable, in vivo interactions.  We also chose to work in 
crosslinked cells, where complex components are covalently fixed together.  In this manner, we 
could identify lncRNAs that act at the same genomic loci as PRC1, without necessarily knowing 
which component(s) of PRC1 or its binding partners (including PRC2) directly bound the lncRNAs.  
Moreover, the covalent fixing of the complexes allowed us to employ more stringent chromatin 
purification, IP, and wash conditions aimed at reducing RNA noise. In order to investigate the 
interactions of lncRNAs with chromatin proteins, such as the PcG proteins, we needed to expand 
the dynamic range of canonical RIP to include lowly expressed lncRNAs and exclude mRNAs.    
 
Development of the Assay 
We set up our system in HeLa cells stably expressing a FLAG-tagged PRC1 component, FLAG-
Bmi1 (25% overexpression) to allow for cross-validation of results between the endogenous and 
tagged protein.  The over-expressed FLAG-Bmi1 in this cell line was shown previously to interact 
with the core components of PRC129.  We further characterized the FLAG-Bmi1 protein by anti-
FLAG immunofish, confirming the protein was indeed localized to punctate bodies on the 
chromatin (Figure 1), typical of endogenous Bmi1(Figure 2). 
A brief description of our technique for discovering PRC1-associated lncRNAs on the chromatin is 
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Figure 3. Schematic of protocol to isolate Chromatin Associated Transcripts (CATs)
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sheared the nuclei. To isolate the chromatin, we applied the nuclear lysate to a CsCl density 
gradient.  Chromatin-containing fractions from the gradient were identified by immunoblot and 
spectrophotometry, and pooled for further purification.  CsCl was removed from the pooled 
fractions by dialysis to prepare the chromatin for IP against the PcG proteins (or various controls).  
Finally, the IP’s were washed in both high and low salt for protein and RNA specificity, 
respectively, and the co-precipitating RNAs were isolated for sequencing (Figure 3).  More 
detailed descriptions of these steps follow. 
 
Migration of biomolecules through the CsCl Density Gradient 
The isolation of chromatin by CsCl density gradient is a major purification step in the protocol. The 
density gradient, once a routine step in early mammalian ChIP, separates the bulk chromatin from 
sources of noise: free nucleic acids, free protein, lipids, and aggregates.  As previously described 
in early ChIP studies 30, free protein is expected to run near the top of the gradient whereas free 
nucleic acids, which are much denser than proteins, are expected to collect at the bottom of the 
gradient.  Chromatin, which is comprised of both nucleic acids (DNA and RNA) and proteins 
(histones, transcription factors, etc) is expected to migrate to the center of the gradient.   
We confirmed previous results outlining the migration of various biomolecules through the density 
gradient.  By Bradford assay, protein ran from the center of the gradient to nearly the top 
(Figure 4).  Immunoblot analysis of specific targets revealed that the chromatin binding proteins 
Bmi1, Suz12, PHC1 and CTCF migrated slightly below the bulk protein, in the central fractions 
(fractions 4,5 and 6) with the histones (Figure 5).  DNA, which is associated with protein and 
largely compacted into chromatin, migrated in the center of the gradient (Figure 6, Figure 7).  The 
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tight co-migration of DNA and chromatin proteins suggested that the DNA was sufficiently 
crosslinked to remain associated with chromatin proteins through the purification.  
 In contrast, RNA collected at the bottom of the gradient, but was also spread throughout the 
bottom and middle of the gradient (Figure 8, Figure 9).  RNA migration at the bottom of the 
gradient can be readily explained by the effect of high salts on RNA binding.  Namely, the high 
concentrations of CsCl ablate weak or non-specific RNA/RNA interactions or non-specific 
interactions between basic patches of protein and RNA, and precipitate free RNA.  RNA 
migration in the central fragments can be explained by crosslinking and protein association: 
Nucleic acids are inefficiently crosslinked to protein by formaldehyde, and are generally retained 
by being trapped in crosslinked protein “cages”.  The presence of RNAs in the bottom and central 
fractions is likely due to RNAs being caged by various protein interactors, and being sheared into 
non-uniform fragments based on RNA secondary structure and RNA/protein interactions 
(footprinting).  Therefore, the crosslinked CsCl gradient serves not only as a means to reduce non-
specific binding, but to then separate much of the contaminating RNA from the chromatin. 
To ensure that lncRNAs indeed remained bound to the chromatin, we probed migration of the 
canonical chromatin bound lncRNAs Xist and h19 RNAs as a proxy of lncRNA retention.  RT-qPCR 
revealed that both Xist and h19 lncRNAs migrated in fractions 4-6, with the bulk chromatin (Figure 
9).  This demonstrates that the Xist and h19 present in the nuclear prep are protein-bound, and 
are sufficiently crosslinked to maintain the interaction through the purification.  
We also examined mRNAs of various transcription levels to assay where mRNA noise might be 
generated from, and to show that retention of RNAs was specific to protein bound RNAs.  We 
found that free nucleotides were precipitated to the bottom of the gradient, whereas highly 
transcribed RNAs (processed or unprocessed) migrated in a single, central fraction.  P68, a 
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fractions if present due to cytoplasmic contamination (free of protein), or possibly in higher 
fractions if being transcribed or shuttled with proteins.  P68 mostly accumulated in the bottom of 
the gradient or was present at levels indistinguishable from untranscribed controls (Oct4) (Figure 
9, Figure 10), indicating that most of the P68 in the sample was free, and separated from the 
chromatin.  Highly transcribed mRNAs such as GAPDH and unprocessed pre-mRNAs (GAPDH 
intron/exon junction normalized to a –RT control) were almost exclusively located in the most 
dense chromatin fraction (4), presumably still tethered to the chromatin and PolII (Figure 10). 
These data suggested that free RNA was indeed migrating to the bottom fraction, chromatin 
interacting lncRNAs were largely retained alongside chromatin proteins, and that mRNA in the 
chromatin fractions were likely tethered to the DNA, presumably at the respective genomic loci. 
We optimized our shearing conditions using Bmi1 and Xist as positive controls to test the effects of 
shearing on PcG-bound lncRNAs.  Xist has previously been shown to interact with PRC2 
components, though direct binding to PRC1 has not been investigated.  However, the high 
abundance of Xist in the cell made it an attractive candidate for RT-qPCR analysis.  Interestingly, 
more intense shearing lead to migration of Bmi1 in the higher fractions, whereas total histone 
migration was not proportionally elevated (Figure 11).  This is consistent with reported shearing-
hypersensitivity of PcG binding sites, thought to be caused by nucleotide bias and a broad 
nucleosome-free region.  Similarly, Xist but not GAPDH migration mirrored the elevated migration 
pattern of Bmi1 (Figure 12).  Accordingly, shearing conditions (4.5 Kbp DNA fragments) were 
optimized to solubilize the DNA (Figure 17) and maintain RNA integrity, while keeping Bmi1 
together with the bulk chromatin.  Only fractions which contained both Bmi1 and the bulk 
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IP specificity 
We immunoprecipitated Bmi1 and FLAG-Bmi1 from the pooled chromatin fractions (fractions 4-6) 
expecting that true PcG-binding lncRNAs would be enriched over input, and cross-validated 
between the two samples.  The FLAG-Bmi1 IP differed from the Bmi1 IP in a number of ways: it 
was performed with a mouse anti-FLAG antibody, was specific for only 20% of the Bmi1 in the 
cell (FLAG-Bmi1), was precipitated with covalently crosslinked agarose beads instead of ProteinA 
coated beads, was subjected to harsher IP conditions and washes (1M Urea), and was eluted 
from the beads via peptide elution (3X FLAG) instead of by SDS.  We additionally performed an 
IP targeting the widely bound transcription factor CTCF (though in smaller scale), to show 
specificity for associations with Bmi1 versus general associations with chromatin.  Finally we also 
performed a (smaller scale) IgG IP, as a universal negative control.  We reserved portions of the 
input and IP eluates for immuno-blot (or silver stain) (Figure 13, Figure 14) and qPCR (Figure 15, 
Figure 16).  These assays verified that the IP’s targeting multiple chromatin proteins were specific 
at the protein and DNA levels.  Of note, the mean length of the DNA from the Bmi1 IP was 3.5 
kbp whereas the input DNA had a mean length of 4.5 kbp (Figure 17).    
 
Identification of candidates: RNAs cross-validate in a non-random fashion 
We sequenced RNA from the input, Bmi1 IP, and FLAG-Bmi1 IP and identified enriched peaks 
which cross-validated between the two samples.  We first aligned uniquely mapping reads from 
each sample, using Bowtie.  Using the program Model-based Analysis of ChIP-Seq31 (MACS), we 
identified read pileups (peaks) in our sequencing data from individual IP samples.   MACS called 
peaks based on read density, peak shape, amplitude, and width, to identify transcripts de novo 







Figure 13. Immunoblot of IP Eluates
Eluates show protein specificity: CTCF and Bmi1 are selectively pulled down in the 
CTCF and Bmi1/FLAG-Bmi1 IP’s.  Similar results seen in >4 biological replicates.  
A non-related lane was electronically removed for figure clarity.
Figure 14. Silver Stain Analysis of IP Eluates
CTCF IP did not show a band in the Immunoblot input. We therefore confirmed 
that the IP shows a single band at the expected size by silver stain
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Figure 15. CTCF-IP shows specificity for CTCF targets
DNA was isolated from the a portion of the IP-eluate.  qPCR was performed at two 
regions of published CTCF binding and an intergenic control. qPCR performed in 
triplicate.  Similar results seen in >3 biological replicates.
Figure 16. Bmi1 IP and FLAG-Bmi1 IP show specificity for 
Bmi1 targets.
DNA was isolated from the a portion of the IP-eluate.  qPCR was performed at two
regions of published Bmi1 binding and an intergenic control.  Notably, FLAG-Bmi1 only 
accounts for 20% of the total Bmi1 in the cell.  qPCR performed in triplicate.  













































































































































































































































The exons are unassembled and may not represent an entire lncRNA due to RNA shearing and 
possible footprinting effects.  Therefore, to compare the samples, we simply considered 
overlapping peaks which were called in both Bmi1 and Bmi1 and FLAG-Bmi1 IPs, and had a 
pvalue from MACS less than 10-15 in both samples.  For each overlapping peak, we then 
calculated the intensity ratios (reads in the IP over reads in the input) to normalize to transcript 
abundance in the input.  We found that the intensity ratios across the entire set of overlapping 
peaks correlated with Rval=.61 (Figure 18).  Significant enrichment over input was further 
determined at each peak using EdgeR32, and overlapping, enriched peaks from Bmi1 and FLAG-
Bmi1 IP’s (pval <.01, fold change > 2) were selected for further study.  These peaks represent 
cross-validated, enriched candidates for PcG interaction. 
We also correlated the log-intensities at annotated regions, and found that the correlation 
occurred only at RNAs from specific regions of the genome.  We first correlated all mRNA exons, 
as annotated by RefSeq33.  Generally, processed mRNAs are expressed at higher levels than 
lncRNAs14,15, and often are used as a metric of false-positives or transient interactions since no 
biology has implicated them in PcG function.  We found that the log intensity ratios across mRNA 
exons were correlated with a low Rvalue of .30 (Figure 19). Of 8,731 mRNA exons expressed 
over background in both IP’s, zero exons were significantly co-enriched between the replicates.  
Conversely, we found that intensity ratios across previously annotated lncRNAs (Ensembl)33,34 had 
Rval = .80, and an Rval = .73 excluding all repetitive regions called by Repeatmasker35 (Figure 
20).  Since lncRNAs are often poorly annotated, we also correlated only regions of lncRNAs with 
signal (MACS peaks within the lncRNAs), excluding repeats.  These peaks had an Rval = .68 
(Figure 21).  Taken together, these data revealed that the correlations were non-random: strong 
at regions of predictive of true interactions, and weak at regions predictive of noise.  



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































source of noise.  Therefore, we had high confidence in our MACS-peak candidates, and the 
enriched, annotated lncRNAs also represented a second set of candidates for PcG interaction. 
 
RT-qPCR validates individual candidates  
We then validated individual RNA sequencing results by RT-qPCR, and incorporated additional 
controls.  We performed RT-qPCR directly on the eluate from the Bmi1 IP, as well as from the 
CTCF IP and the IgG control from matched input (Figure 22).  We examined Xist, which has been 
proposed previously to interact directly with EZH2 of PRC2, and which, specifically the RepE 
domain, was also the top hit of our de novo peaks (Figure 23).  RT-qPCR revealed that Xist RepE 
was highly enriched in the Bmi1 IP, but not in the IgG or CTCF IP.  The functionality of Xist in this 
cell line was supported by RNA-FISH of Xist, showing that each cell had a single, distinct barr 
body (Figure 24). Conversely, h19 (Figure 22, Figure 25), which has not been shown to interact 
directly with PcG proteins, was not enriched in the initial sequencing experiments or by RT-qPCR.  
ANRIL, which has been previously implicated to play a role in Bmi1 mediated regulation of the 
Ink4a/Arf locus, was mildly enriched in the Bmi1 IP sequencing data, but not the FLAG IP 
sequencing data. Because of this lack of cross-validation, and because the cell-cycling role of 
ANRIL in a cancer line is unclear, we could not interpret it as a control and did not pursue it by RT-
qPCR.  Overall, these data confirm that the sequencing results were specific in comparison to IgG 
and CTCF. 
We next confirmed our results by performing a biological replicate of the FLAG-Bmi1, Bmi1 and 
IgG IP’s.  By comparison with the replicates (via IP/RT-qPCR) we identified reproducible 
candidates, removed IgG non-specific peaks, and demonstrated relatively low variability in the 

































































































































































































































































































































































































































above (NuGeN kit) and performed qPCR on a number of candidates from each IP/input in the 
replicate experiment.  Once again, Xist was enriched in the pulldowns of Bmi1 or FLAG-Bmi1 as 
compared to the IgG; GAPDH and h19 were not (Supplemental Table 1).  We expanded our RT-
qPCR screen to target sixty-three candidates in addition to Xist, GAPDH, and h19.  Candidates 
were selected from co-enriched MACS peaks for validation based on: intergenic location, p-value 
as assigned by EdgeR, the absence of large repetitive regions (RepeatMasker), and peak width 
greater than 500 bp.  We also gave higher weight to peaks aligning to previously annotated 
lncRNAs.  Trying up to two amplicon pairs per peak, we found that 42 candidates were validated 
in the replicate pulldowns but not the IgG, 6 did not reproduce and were higher in the IgG, and 
15 candidates consistently gave multiple melt curves, and were not interpretable.  This yields a 
minimum 66.7% validation rate. These transcripts became our top candidates for PRC1 
interaction. All results summarized in Supplemental Table 1. 
We surveyed the 65 initial candidates for sequence motifs, though did not find any strong 
sequence bias.  However, though we considered only uniquely mapping reads, many candidates 
contained tandem repeats36.  More precisely, many candidates contained ~40-200bp sequences 
that were repeated with modest fidelity (~75%) along a single, contiguous region of the genome.  
These domains might account for the difficulty in obtaining single melt curves for many candidates 
by RT-qPCR. Furthermore, such domains may also be highly structured, and could represent a 
structural class of PcG-interacting lncRNAs. 
 
Expression levels, nuclear localization, and tissue-specificity of the candidates 
After showing non-random candidates had a high validation rate, we further characterized our 
highest-confidence candidates.  We assayed the dynamic range of the experiment (with respect 
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to candidate expression level), localization of the candidates in the cell, and expression of the 
candidates in biological tissue. 
The expression levels of our candidates varied widely.  On average, the top 100 MACS peaks 
selected had an rpkm (reads per kilobase per million) of 0.48 in the input, yet about 7.71 in the 
Bmi1 IP (Figure 27, Figure 28, Figure 29).  As a reference, Xist Rep E, which was our top 
candidate as ranked by p-value assigned by Edge-R, had an rpkm of 3.78 in the input and 
34.43 in the IP (Figure 23).  This showed us that our protocol was identifying candidates 
expressed at a wide range of abundances. 
Based on prior evidence that lncRNAs modulate the PcG protein activity on chromatin, we verified 
that the candidate lncRNAs were indeed appreciably retained in the nucleus.  We mined cell-
fractionated RNA-seq data, publicly available from ENCODE.  These data included matched 
whole-cell, nuclear and cytoplasmic RNAseq data, obtained from ten different human cell lines, 
including a HeLa line.  For the 65 RT-qPCR verified targets, we verified 53 were primarily 
localized to the nucleus, 6 were both nuclear and cytoplasmic, and 7 had insufficient data to 
determine localization (e.g. 53/59 verified; 42/42 of which were replicated by RT-qPCR) 
(Supplementary Table 1). 
Finally, we characterized expression of these lncRNAs, found in HeLa cells, in a biologically 
relevant setting.  RT-qPCR was performed for selected candidates across RNA from 20 tissues in 
the body, placenta, and developing fetus, as well as in embryonic stem cells.  We saw that these 
lncRNAs were indeed present in various tissues of the body, and were not simply artifacts 
exclusive to HeLa cells.  Furthermore, each candidate was differentially expressed in a tissue-
specific manner (Figure 26).  These results show that we have generated a high-confidence, cross-
validated list of non-random lncRNA candidates that may be working with the PcG proteins across 



























Figure 26. Relative expression of selected candidates across a variety of human 
tissue.  
“Chromatin Associated Transcripts” (CATs) from our screen appear to be expressed in 
a tissue specific manner across the body.  RT-qPCR was performed in triplicate and 
mean expression of select CATs is shown relative to GAPDH.  Signal is further normal-
ized to the mean value across each column.  Hierarchical clustering using a Euclidean 






















































































































































































































































































































The molecular understanding of gene regulation has shifted to include lncRNAs as regulators of 
transcription.  However, techniques to identify such lncRNAs remain limited in specificity and 
dynamic range.  Our technology identifies a broad spectrum of chromatin-interacting lncRNAs, 
expressed at a variety of levels.  By relying on a clean chromatin input, stringent washes geared 
at RNA specificity, and cross-validation techniques, we have nearly eliminated mRNA 
contamination from our top peaks: a metric of noise that plagues canonical RIP reactions.  
Applying our technology to the PRC1 protein, Bmi1, we generated a list of candidates that 
potentially interact with PRC1, and/or its binding partners.   
Previous RIP or CLIP studies have targeted PRC2 components to study PcG/lncRNA binding.  In 
particular, many sources have searched for RNAs by EZH2 binding.  However, recent reports state 
that EZH2 promiscuously binds RNAs in vitro and in vivo 2,18.  It remains unknown which protein(s) 
confer specificity to PRC2 in vivo. Our IP protocol uses crosslinked complexes, allowing us to 
identify RNAs at sites of PRC1 binding, without assuming which PRC1 protein(s) –  or which PRC1 
binding partner, such as PRC2 – the RNA directly binds.   
Our RNA candidates not only cross-validate between biological replicates, but also are enriched 
in a parallel immunoprecipition of a stable FLAG-Bmi1.  Overall, the FLAG-Bmi1 and endogenous 
Bmi1 IP’s correlate well, and, importantly, in a non-random fashion that is not driven by 
expression level.  Namely, the correlation is strong at regions of putative positive control 
(lncRNAs) but much weaker at regions of noise (mRNA exons). 
Among our candidates, we have identified a functionally novel region of Xist as the top hit.  
Though Xist has been shown to bind to EZH2 at its RepA locus in vitro 11, RepA deletion does not 
58
result in PRC1-component delocalization from the inactive X chromosome (personal communication, 
Neil Brockdorff), and generally, PRC1 components are dispensable for X inactivation37.  
Furthermore, though localization of PRC1 components to the chromatin has been reported28,37,38, 
the direct interaction of PRC1 with Xist has not been investigated.  We found striking enrichment 
of Xist signal precisely over RepE, rather than at RepA .  RepE is near the 3’ end of Xist, and its 
function remains elusive.  Our results suggest that RepE may play a role in recruitment of PRC1 
proteins to the inactive X. 
A large number of the top candidates contained tandem repetitive regions that were unique to a 
single, contained area of the genome – such as RepE.  Sequence analysis of top candidates did 
not reveal any significant binding motif, though many candidates were modestly C-rich.  Taken in 
the context of PRC2 lacking definite sequence specificity and yet binding to the highly structured 
domain RepA , it is possible that these tandem repetitive regions constitute a structural class of 
PcG target lncRNAs. 
 
Conclusion: 
Our method identifies nuclear, non-random RNAs that interact with chromatin proteins.  As 
demonstrated with the PRC1 protein Bmi1, associated RNAs cross-validate at regions of expected 
signal, but not at noise.  Our candidates are expressed in the body, largely localized to the 
nuclei, and often contain short tandem repeats.  Moreover, they range from very high abundance 
in the cell, such as Xist RepE, to lower abundance transcripts, which are readily discernable from 
negligible mRNA noise.  These RNAs constitute a class of lncRNAs, we refer to as Chromatin 
Associated Transcripts (CATs).   Moreover, this protocol works for a variety of proteins/antisera, 
supporting its applicability to other systems, such as perhaps Oct4/Sox2/Nanog proteins in ES 
cells, to find CATs involved in maintaining the ES cell state.  Our list of PRC1-interacting CATs are 
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strong contenders for true PcG interaction.  Further validation is necessary in order to integrate 
them into the PcG gene-regulatory network. 
 
Methods 
Cell Culture and crosslinking 
HeLa cells stably transduced with a copy of FLAG- tagged Bmi1 at approximately 25% 
overexpression29 were cultured in DMEM supplemented with 10% FBS (Sigma), NaHCO3 pH 7.5 
and gentamycin.   Cells were grown in suspension in a spinner flask (Matrical) to a density of 
approximately 3x108 cells per liter.  The cells were crosslinked at 1% formaldehyde for 20’ in 
PBS at room temperature with light rocking. 
 
Nuclei prep, Sonication and CsCl Gradient 
All steps were performed in the presence of RNAsIn plus (Promega) RNAse inhibitor, DTT, .05 mM 
Spermine, .05 mM Spermidine, and Complete EDTA-free Protease inhibitor tablets (Roche). 
Crosslinked HeLa cells were resuspended in LB1 (50 mM Tris 7.4, 140 mM KOAc, 1 mM EDTA, .5 
mM EGTA, 10% glycerol, .5% NP-40, .25% Triton X-100, .1% digitonin) and spun to isolate 
nuclei and porate the nuclear membrane.  The porated nuclei were then dounced in LB1 using a 
Wheaton homogenizer type A and applied over a glycerol pad (25% glycerol, 1 mM EDTA, .5 
mM EGTA, 10 mM Tris pH7.4) to further separate cytoplasmic debris and expelled nucleoplasm.  
The nuclei were rinsed in LB2 (Tris pH 7.4, 10 mM EDTA, 5 mM EGTA and 200 mM KOAc), 
resuspended 1:1 in LB2 and sheared using the Covaris S2 machine (30 minutes at 20% Duty 
cycle, power 7 and 200 cycles/burst, in 30 second intervals; 700 uL aliquots).  The sheared nuclei 
were then resuspended (dropwise) in LB2 with 3.37M CsCl and .1% Sodium Sarkosyl, and spun 
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for 48 hrs at 200,000 g at 8 degrees Celsius to form a density gradient.  Fractions were 
collected by a peristaltic pump in aliquots of 1/10 the total volume. 
 
Immunoprecipitation 
Selected fractions were pooled and dialyzed (MWCO 3,500 kDa) for >5 hours in LB2 containing 
5% glycerol at 4 degrees Celsius.  Following dialysis, .05% NP-40 and .5% Triton X-100 was 
added as well as 100 mM urea (or 1 M urea for immunoprecipitations against FLAG).  The 
material was then spun out and moved to a new tube to ensure removal of any aggregates.  Less 
than 5% loss was checked by spectrophotometry at A260 and samples were normalized in the 
same buffer to 800 ng/uL.  The material was then pre-cleared for 45 minutes with IgG-Agarose 
beads (Sigma).  Dynal protein A beads (Invitrogen) were pre-bound to antibody with blocking by 
RNAse-free BSA (Ambion).  The pre-bound beads, or covalently conjugated FLAG-agarose beads 
(Sigma) rinsed in LB2 were added to the input and incubated at 4o Celsius overnight with light 
rocking.  Beads were washed at room-temperature four times in IP buffer and twice in IP buffer 
with reduced salt (25 mM KoAc).  The immunoprecipitated material was eluted from Dynal beads 
in 1% SDS and 1mM EDTA or from M2 agarose beads with 3X FLAG peptide as described by 
Sigma.   Crosslinks were reversed for 1.5 hrs at 65o Celsius in the presence (RNA isolation) or 
absence (Protein and DNA isolation) of 1U/uL proteinase K (Roche). 
 
RNA isolation, cDNA generation and library construction 
Either input RNA or RNA from the immunoprecipitation was stored in Trizol LS (Invitrogen) 
following crosslink reversal and proteinase K treatment.  Chloroform was added and the sample 
was spun out according to the manufacturer’s instructions.  The aqueous phase was applied to 
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Zymo Clean-and concentrator 5 columns and DNAsed “in tube”as per the manufacturer’s 
instructions for RNAs larger than 200 nucleotides.  cDNA was generated using the NuGEN RNA 
Ovation FFPE kit (7150-08), or by SuperScript VILO (Invitrogen).  For library generation, cDNA 




Antibodies for immunoprecipitations targeted either FLAG (M2) (Sigma #M8823); Bmi1 (rabbit 
polyclonal antisera39, or CTCF (Active Motif #39621).   Immuno-blots and IF were carried out 
using primary antibodies as above, Suz12 (ab12703), pan-H3 (Abcam ab1791), or Clean-Blot 
HRP-conjugated secondary antibody. 
 
RNA-FISH and Immunofluorescence (IF) 
RNA FISH and IF was performed as previously published40 using a CSK pre-extraction to 
permeabilize the cells.  The construct targeting Xist was a gift from Dr. Judith Sharp, and was first 
used in the above work. 
 
Immuno-blots and Silver Stain 
Protein was either isolated from CsCl fractions by TCA precipitation and reverse-crosslinked in 
SDS as above, or loaded from the crosslink reversal stage from the immunoprecipitations.  A final 
concentration of 0.5U/uL Benzonase (Novagen) was added to each sample with Lamelli Buffer 
and incubated at room temperature for 10 minutes followed by 10 minutes of boiling prior to 
SDS-PAGE.  Antibodies were used at 1/4000 (Bmi1, Pan-H3) or 1/1000 (CTCF, Suz12).  Silver 
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staining was performed with the SilverQuest kit (Invitrogen) according to the manufacturer’s 
instructions. 
 
DNA isolation and qPCR 
Reverse-crosslinked eluate from immunoprecipitations was treated with DNAse-free RNAse 
(Roche) followed by Proteinase K (Roche) and subjected to phenol chloroform isolation.  The 
aqueous phase was then ethanol precipitated with glycogen and NaCl.  All qPCR was performed  
using Biorad iTaq with SYBR and ROX.  A list of all primers used is compiled in Supplementary 
Table 1. 
 
Peak calling and Significance using MACS and EdgeR 
Uniquely mapped reads were aligned to the hg19 build of the genome.  MACS31 was used to 
call peaks over regions of read pileups.  We used default parameters with the exception of the 
p-value, which was selected at 10E-15.  Overlapping MACS peaks were defined as having as 
little as 1 bp overlap.  Peaks were merged between Bmi1 and FLAG-Bmi1.  Because MACS 
assumes a flat input (e.g. as for ChIP), we also assayed for significance relative to the input in two 
ways: by EdgeR32 and by using MACS itself with an input control.  All peaks reported were highly 
significant by p-value by either method.  EdgeR also imposed intensity cuts as reflected in the p-
value.  Necessarily, we did not pay attention to the FDR because many peaks were expected in 
the input that were not in the IP data.  We chose peaks with pval <.01 and fold change >2, as 
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While a growing body of work has shown that the Polycomb group (PcG) proteins interact with 
long non-coding RNAs (lncRNAs), discerning true interactors from artifacts has proven extremely 
challenging.  Here, we consider 17 novel candidates previously shown to interact with the PRC1 
component Bmi1, and/or its binding partners in vivo, in HeLa cells. We find that siRNA depletion 
of 11 of the 17 individual candidates show widespread changes in the transcription of PcG-
regulated genes.  Furthermore, we show that depletion of one of our candidates, CAT7, leads to 
upregulation of the activating transcription factors the Trithorax group proteins, lysine-specific 
histone demethylases, and an array of homeodomain-containing genes.  In addition, loss of CAT7 
causes derepression of the moderately close (400kbp away) gene Mnx1, as well as loss of PcG 
binding at the Mnx1 promoter.  Examining loss of CAT7 during motor neuron differentiation from 
embryonic stem (ES) cells, we find that several essential regulators of neuronal development, such 
as the PcG/Shh regulated Mnx1, Irx3 and Isl1, and many PcG-silenced genes in ES cells, show 








Long non-coding RNAs (lncRNAs) are emerging as genomic regulators which govern the 
transcriptional machinery.  However, integration of IncRNAs into existing, protein-based models of 
gene-regulatory networks remains challenging.  lncRNAs have been suggested to interact with 
protein complexes as tethers, allosteric switches, scaffolds, and protein evictors 1.  However, 
regulatory lncRNAs remain difficult to identify, and it is harder still to understand how they 
execute changes to gene expression.   
Many lncRNAs have been shown to impact gene expression by modulating activity of transcription 
factors.  Technologies such as RNA Immunoprecipitation (RIP) have been employed to identify 
transcription factor/RNA interactions.  However, RIP is beleaguered with noise from non-specific 
RNA/RNA and RNA/protein binding 2,3.  These artifacts often overwhelm true signal, making RIP 
ineffective at generating novel hypotheses for biological validation. 
In the previous chapter, we developed a technology to identify lncRNAs that interact with 
chromatin proteins.  Our protocol drastically reduces mRNA contamination (a readout of noise) to 
expand the dynamic range of RNAs pulled down in a canonical RIP.  We applied our technology 
to Bmi1, a Polycomb (PcG) protein that is part of a complex (PRC1) important for stable 
chromatin silencing and compaction.  The output of our protocol was a list of lncRNAs candidates 
that interact with Bmi1 (PRC1), or its binding partners, potentially including another PcG complex, 
PRC2.  These lncRNAs are of high interest because they represent candidate interactors of the 
PcG proteins at sites of stably silenced chromatin. 
A growing body of work has implicated PRC2 in direct lncRNA binding 4-8, whereas PRC1 has 
remained largely unexamined.  Though the precise role of lncRNAs in PcG mediated silencing has 
not been mechanistically established, much of the above evidence suggests that lncRNAs may 
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impact PRC2 component localization at specific sites on the chromatin.  PRC1 binding is often 
preceded by PRC2 activity on the chromatin and in some instances, may require PRC2 and/or the 
product of PRC2 on the chromatin (H3K27me3) for proper localization.  Notably, H3K27me3 is 
not necessary for all PcG-mediated silencing. 
Recently, however, the veracity of many lncRNA/PRC2-interactions found by RIP has come into 
question.  Several studies have shown that a component of PRC2, the methyltranferase EZH2, 
binds random RNAs in vitro, and also without sequence specificity in vivo 9,10.  Indeed, it is not 
known which components (if any) of PRC1/2 confer specificity in regards to RNA binding.  These 
technical challenges demand that a higher standard of evidence is presented before a lncRNA is 
validated as part of the PcG gene network.  Furthermore, there is a stark lack of biological 
validation from the resulting lncRNAs from PRC2-RIP screens.  In order to assess the role of a 
lncRNA as it relates to PcG biology, not only should the lncRNA show interaction with the PcG 
proteins, but perturbation of the lncRNA should also exhibit an impact on the PcG-mediated gene-
regulatory network or some aspect of PcG function 7,8.  Such biologically motivated criteria might 
include the ability of a lncRNA to affect PcG binding and/or expression of PcG target genes. 
Our list of candidates from Chapter 2 represents a non-random set of putative PcG interactors 
that have been cross-validated, biochemically purified from a major source of noise (mRNAs), and 
found in nuclei of various tissues of the body.  We therefore capitalized on our unique position to 
further investigate the role of lncRNAs in the PcG biology.  Namely, we screened our candidates 
for effects on PcG-regulated targets and, after identifying interesting candidates, examined the 
role of a lncRNA in PcG recruitment at an affected locus.  Finally, we probed the role of one of 




Strategy to identify candidates for functional studies 
To better understand the function of our lncRNAs in the cell, and particularly in relation to PcG 
biology, we designed a basic screen to identify which candidates functionally impact gene 
expression of PcG targets (Figure 30).  Specifically, we reasoned that knocking down a lncRNA 
candidate might affect recruitment or assembly of PcG proteins at a repressed locus (or loci).  As 
a result, the PcG proteins would no longer be able to repress expression of target gene(s) at the 
affected locus or loci, leading to an increase in gene expression at those site(s).  Therefore, our 
screen consisted of knocking down RNAs and searching for changes in the transcriptome (RNAseq) 
relative to a scramble control. 
We further considered that indirect effects of modifying PcG activity would also impact the 
output of the screen.  Characteristically, PcG proteins silence master regulators of transcription.  
Moreover, several PcG-regulated genes might be directly affected by perturbing the same locus, 
such as genes organized in a PcG body.  It follows that increased expression of such PcG targets 
could potentially enact a signaling cascade, affecting entire gene networks.  Therefore, de-
repression of PcG targets would not necessarily imply a direct interaction of a lncRNA with the 
chromatin at the target sites, or even that the change in expression was caused by loss of PcG 
binding.  However, such a perturbation in the PcG gene network might be readily discernible 





Application and analysis of the screen 
We selected seventeen of our top PRC1-interacting candidates in HeLa Bmi1F17 cells11 (where 
they were first isolated), alongside Suz12 (of PRC2), Bmi1 (of PRC1), Xist lncRNA and scramble 
controls, to screen by this method.  In choosing our lncRNA candidates, or Chromatin Associated 
Transcripts (CATs), we ranked candidates by p-value (EdgeR) but selectively included 9 
candidates mapping back to previously annotated lncRNAs.  CATs came from both unannotated 
and annotated lncRNA regions of the genome, but even the annotated CATs were primarily 
located in lncRNA introns, usually on the same strand.  We also included one candidate which 
shared an exon with the transcript of CISTR-ACT, a chromatin interacting lncRNA upregulated in 
Brachydactyly 12.  The CISTR-ACT overlapping RNA was not among our top candidates, but was 
recently proposed to control changes in chromatin structure and expression, and to directly 
interact with chromatin near PcG binding sites.  We also selected 9 of the top candidates which 
contained tandem repeats: short (20-200 nucleotides) repeated with ~75% fildelity across a 
single region of the genome, and called by Tandem Repeat Finder13.  Such peaks are predicted 
to be highly structured, and were selected based on the previous finding that RepA, a tandem 
repeat found in Xist, binds to PRC2 components.  Notably, Xist was also enriched in our screen 
and selected as a candidate for knockdown. However, our results suggested a strong enrichment 
precisely at the RepE locus of Xist, rather than at RepA (Figure 22-Figure 25). 
We opted for an RNAi methodology that would increase the likelihood of knockdown in the 
nucleus.  This decision was based on the hypothesis that our candidates acted directly on the 
chromatin, and also on prior cell fractionation data from ENCODE 14 suggesting many of our 
candidates are primarily localized to the nucleus.  We chose to knockdown candidates using 
siRNAs, in order to avoid the need for shRNA processing.  We also used nucleofection, which 
electroporates the cellular and nuclear membranes, to efficiently deliver the siRNAs into the 
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nucleus.  After 48 hours (post nucleofection) in standard culture conditions, we harvested the total 
RNA from the cells to test knockdown efficiency by RT-qPCR.  Following knockdown validation, we 
sequenced the (ribosomally depleted) total RNA to search for changes in transcriptional gene 
networks. 
We developed a data pipeline to identify changes in gene expression following lncRNA 
knockdown (Figure 30).  For each candidate, only uniquely mapping, non-duplicated reads, were 
aligned to the genome, yielding approximately 15M aligned reads per sample.  The total 
aligned reads were normalized in the scramble sample for each comparison to a knockdown 
sample.  We confined our comparisons to mRNAs annotated by Refseq15.  We then analyzed the 
number of reads mapping back to each mRNA transcript, including various isoforms of the same 
gene.  Transcripts were considered if they had signal above background in both the scramble and 
the knockdown transcriptomes.  The list of genes (identified by gene name to avoid bias from 
multiple isoforms) represented the total set of expressed genes.  We then broadly filtered the set 
of expressed genes, selecting genes with greater than 2-fold or less than 50% signal relative to 
the scramble control.  This set was designated as the “changed-genes” for each knockdown. 
We characterized each list of changed genes to find significant overlap with PcG-regulated 
genes.  To analyze our data for enrichment of functional data sets, we submitted a list of changed 
genes to the data compendium, the Molecular Signatures database16, for each knockdown 
experiment.  We then identified which of 6,791 previously curated gene-sets showed significant 
overlap with the changed-genes for a knockdown.  These gene sets included transcription factor 
motif binding sets, gene ontology sets, and curated pathways, such as protein reactome gene sets. 
Among these gene sets were PcG and H3K27me3 target gene sets from ChIP data, as well as 
sets of genes whose transcription changed after PcG protein depletion (RNAseq data), from an 
array of cell lines.  To calculate significance for the intersection of a particular gene-set with a list 
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Knock down a lncRNA 
by siRNA nucleofection
48 hours (HeLa)
72 hours (Motor Neurons)
Harvest RNA to assess knockdown 
and make libraries for sequencing
Compare gene expression in lncRNA KD 
vs Scramble KD cells
Select genes above background with >2 fold 
or less than 50% expression versus scramble control
Search for signicantly overlapping gene 
sets in the Molecular signatures Database 
If PcG or H3K27me3 gene sets show signicant overlap
(top 10) select the candidates for further investigation
Figure 30. Strategy to identify lncRNAs 
that perturb the PcG gene-regulatory 
network
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of changed genes, we only considered genes in any list (or gene background) that were 
expressed in the cell and were identified in the Molecular Signatures database.  We then 
generated p-values and expected values for overlaps to ensure significance of our findings. 
We first applied this strategy to identify expression changes from Bmi1 and Suz12 depletion, as 
positive controls (Figure 31).  We independently knocked each mRNA down using single clones of 
previously published siRNA sequences 17,18.  However, despite showing 81.5% mRNA knockdown 
after 48 hours (versus a scramble), Bmi1 protein levels persisted near WT levels (Figure 32), 
presumably due to the long protein half-life in the cell.  As a result, we did not expect to see 
many changes in gene expression.  We found 157 changed-genes, largely biased towards 
membrane biology (pval = 4.07E-23) and probably a result of membrane damage during 
nucleofection.  In effect, the Bmi1 knockdown served as a baseline control and validation of 
effective RNAi, rather than a comprehensive list of gene targets sensitive to loss of Bmi1. 
Conversely, we observed significant mRNA and moderate protein reduction in Suz12 knockdowns: 
69% of mRNA and more than 50% of protein was depleted (Figure 31, Figure 33).   RNA-seq 
revealed 2-fold (or 50%) expression changes in 236 genes, several of which included other PRC2 
components.  This is consistent with previous reports of destabilization of PRC2 upon perturbation 
of any of its core components.  Analyzing the set of changed genes, we saw a mild overlap with 
PRC2 target gene sets in the Molecular Signatures Database, which came from a wide range of 
cell types.  The relatively moderate effect might be attributed to the residual protein in the cell 
(Figure 33).  While this control also did not produce a comprehensive list of every gene impacted 
by Suz12, it revealed that many PcG targets were indeed susceptible to changes in expression 
due to loss of a PcG protein, and identifiable in the context of this assay. 
We then verified that our siRNAs could enter the nucleus by knocking down Xist (RepE).  Xist is a 
highly abundant, nuclear lncRNA which silences the X chromosome in female cells.  It is notoriously 
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Figure 31. siRNA knockdown of Bmi1 and Suz12 mRNA after 48 hours.
Single siRNA clones were nucleofected into HeLa cells  Target mRNAs are identified on the X-axis.  After 
48 hours, Suz12 or Bmi1 expression was examined by RT-qPCR (triplicate) in the respective knockdowns 
as well as a scramble control.  Each lane was normalized to GAPDH signal, and then further normalized 
for each primer set such that the scramble was 100%. All primer sets spanned exons.  Biological repli-





















Figure 32. Immunoblot of Bmi1 knock-
down after 48hrs
Bmi1 protein persisted even 48 hours after 
siRNA treatment.
Figure 33. Immunoblot of Suz12 knock-
down after 48hrs
Suz12 protein showed significant knock-
down 48 hours after siRNA knockdown.  













































difficult to deplete in the cell and yields minimal changes in expression, even with significant 
knockdown.  However, we used Xist knockdown as a control to firstly confirm the siRNAs were 
entering the nucleus, and secondly to gauge background changes in expression.  We saw a 
predictably modest 52% knockdown of Xist, and a relatively low number of changes in mRNA 
expression overall (141).  There was no apparent bias towards changed expression of genes on 
the X chromosome (3/141).  Once again, a significant portion of the changed genes were 
membrane proteins, likely a consequence of the nucleofection process, rather than a specific 
effect of the siRNA.  This experiment demonstrated that our siRNAs were active in the nucleus, and 
gave a relative baseline of expression changes similar to the Bmi1 mRNA knockdown. 
To investigate the role of our lncRNAs in the cell, we subjected seventeen of our novel candidates 
to this screen.  We first verified that off-target effects were minimized in the cell for each 
knockdown.  Explicitly, all knockdowns were performed using 2 unique siRNAs per candidate, 
versus a control scramble siRNA.   The siRNAs were initially verified by BLAST19 for sequence 
specificity (14 or fewer bp of homology to RefSeq-annotated transcripts).  Whole transcriptome 
sequencing (RNAseq) of the knockdowns revealed that none of the most similar mRNA targets (by 
sequence) were significantly downregulated after 48 hours. 
Applying the same analysis as for the control knockdowns above, we found that knockdown of 
most of the candidates affected PcG-related gene expression, without affecting expression of the 
core PcG proteins themselves.   Of the 17 additional lncRNA candidates (besides Xist), 11 showed 
enrichment for gene sets relating to PRC2-regulated or H3K27me3 genes (Figure 34, Figure 35).  
In fact, excluding plasma membrane related gene sets, PcG-related sets were consistently among 
in the top ten most enriched gene sets in these knockdowns, and additional PcG-related gene sets 
were also enriched throughout the top 100 enriched gene sets.   Importantly, the PcG related 
changed genes from each knockdown were not identical, expression of the core PcG proteins 
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 (if by chance)
Figure 34. Genes with changed expression after CAT12 knockdown show significant overlap with 
PcG-related gene sets.  
Total RNA from a lncRNA knockdown and scramble was sequenced. and aligned to genes.  Genes 
expressed above background and showing >2fold (or less than 50%) expression relative to a scram-
ble control were analyzed.  Here, we show the gene set for CAT12 knockdown. Selected gene sets 
were identified by the Molecular signatures database.  p-values and expected overlaps were calcu-
lated using a hypergemetric distribution, only considering genes that were expressed above back-
ground in the cell and found in the Molecular Signatures database.   Isoforms were not included to 
avoid bias.
Figure 35. Knockdown of 11 of 17 candidates resulted in perturbations of the PcG gene 
network
Knockdown of individual candidates caused widespread changes to expression of PcG regulated 
genes or their targets.  By this measure, the majority (11/17) candidates tested were found to be 
involved in PcG gene-regulatory networks.  Knockdown of 3 individual candidates did not widely 
impact PcG gene networks, but may be involved in other biological functions.  Knockdown of 3 










themselves was unaffected, and no genes other than plasma membrane genes were changed in 
every assay.  We ranked these 11 lncRNAs as high priority candidates for PcG interactions. 
The top enriched gene sets in this analysis consistently suggested PRC2 involvement.  However, we 
refrained from making any conclusions about these candidates regarding PRC1 versus PRC2 
biology because the number and size of the gene sets included in the Molecular Signatures 
database were biased towards PRC2 (versus PRC1).   This bias might be due to the (generally) 
poor quality of PRC1 antisera in regards to generating PRC1 component ChIP data sets, the 
availability of H3K27me3 data sets, and also by the redundancy and longer half-life of PRC1 
proteins in knockdowns or knockout data sets.  Instead, we chose to use PRC2 related gene sets as 
a proxy for general PcG activity. 
Of the remaining six targets which did not show significant enrichment with PcG gene sets, one 
lncRNA was enriched for general metabolism genes, another for cell proliferation genes (perhaps 
S-phase), and a third for mitochondrial/electron transport chain related genes.  The results are 
summarized in Supplemental Table 2. Lastly, the changed genes from final three targets did not 
show any overtly recognizable gene ontology.  While a lncRNA may easily be regulating an 
aspect of PcG biology without exhibiting widespread changes to the PcG gene network, such 
pheonotypes are not readily recongnizable by this assay. Therefore, we considered these six 
candidates as less likely to be true PcG interactors.  We conclude that 11 of the 17 lncRNAs that 






Impact of CAT7 KD on PcG binding 
After identifying 11 candidates that disrupt the PcG gene network, we wanted to further 
investigate individual candidates for a role in PRC1 biology.  We tested if upregulated PcG 
targets were coupled with a loss of PcG protein binding at the promoter sites.  We were 
particularly intrigued by one lncRNA whose knockdown resulted in changes not only of PcG 
regulated gene targets, such as homeodomain proteins, but also caused upregulation of Trithorax 
group proteins (MLL1-4, SETD1B), several Jumanji-domain containing proteins, and an assortment 
of transcription factors and other chromatin proteins.  This lncRNA, referred to as “Chromatin-
Associated Transcript 7” (CAT7), is a 1.7 kbp, polyadenylated, capped RNA, composed of a 
single exon (Figure 36, Figure 37, Figure 38) (by RACE-PCR) and largely overlaps with a tandem 
repeat.   
We next searched the genomic environment in the vicinity of CAT7, and found that CAT7 was 
encoded on the same strand as an intron of a previously annotated EST/lncRNA of unknown 
function.  This may be due to a poor annotation of the lncRNA, which is not expressed at 
annotated exons.  Broadly, CAT7 is located in an EZH2-rich gene desert between the 
developmental patterning gene Sonic Hedgehog (Shh) and the testis-specific gene, RNF32 (Figure 
39).  Large deletion mutants of the syntenic region in mouse showed massive misregulation of Shh 
patterning in developing mouse embryos.  These defects are thought to be due to loss of enhancer 
elements. Notably, CAT7 is not conserved in mouse based on sequence or the presence of a 
tandem repeat in syntenic regions.  
We also noticed that CAT7 was transcribed directly 5’ to another EST of the same strand, a liver-
specific lncRNA transcript, and wanted to explore the role of CAT7 in regulation of this transcript.  
Based on previous data from ENCODE, the putative promoter/enhancer region (directly 5’ of the 



































Figure 36. RT-qPCR of CAT7 lncRNA knockdown in HeLa (GAPDH normalized)
HeLa cells were nucleofected with siRNA targeting  CAT7 lncRNA or a scramble control.  RNA was 
extracted and RT-qPCR for CAT7 and GAPDH was performed.
Figure 37. Northern Blot reveals CAT7 is primarily nuclear and is efficiently knocked down.  
Nuclei and cytoplasm were separated, and RNA was isolated from each.  Northern of CAT7 in 
celluar compartments reveals that CAT7 is primarily nuclear. Similarly, Northern analysis shows 
that knockdown is observed in nuclear extracts upon siRNA treatment. All lanes have 20ug 





Figure 38. CAT7 Enrichment in IP vs Input by RNAseq, and the Surrounding Genomic Landscape
A nearby liver specific transcript and TF binding site, and a tandem repeat region are highlighted.
Liver specific TF binding
Liver specific transcript
CAT7 lncRNA






























































































































































































































Receptor binding site, several HNF and Forkhead transcription factor binding sites, and a CTCF 
binding site (Figure 38).  Presence of these proteins, as well as RNA PolII, were almost exclusively 
shown in liver with the exception of CTCF binding, which was present in a wide array of cell lines.  
We were surprised to see that genes with altered expression in the CAT7 knockdown do not 
significantly overlap with gene sets pertaining to liver-related functions, at least in the context of 
HeLa cells.  Additionally, the liver-specific lncRNA adjacent to CAT7 is not transcribed in either the 
scramble or the knockdown samples.  However, many differentially expressed genes are PcG 
regulated genes, such as Mnx1 (up) and Irx3 (down), which are also regulated by Shh signaling, 
or, in the case of HoxA13 (up), control overlapping developmental processes 20.  
We then tested whether overexpression of a PcG target gene in the CAT7 knockdown was 
accompanied by a loss of PcG binding at its promoter. We were particularly intrigued by the 
overexpression of Mnx1 (Figure 40, Figure 42) because it is located reasonably close to CAT7 
(~400kbp away on the same chromosome), on the border of a neighboring gene desert (Figure 
39).  In addition, Mnx1 was also overexpressed (2.1 fold) in the Suz12 knockdown, but not as a 
consequence of any other lncRNA knockdown.  To test if loss of CAT7 caused a loss of PcG protein 
binding at Mnx1, we performed ChIP, targeting Bmi1, Suz12, and H3K27me3 in CAT7 
knockdown versus scramble cells.  We observed a 27% loss in Suz12 binding, a 34% loss in 
H3K27me3 signal, and a 22% loss in Bmi1 binding at the Mnx1 promoter in knockdown cells.  
Conversely, we saw almost no loss of ChIP signal at the control locus (HoxB6), and minimal signal 
in all IP’s at an intergenic, negative control (Figure 41).  These data show that knockdown of CAT7 













































































































































































































































































































































































































































































































































Perturbation of CAT7 during motor neuron differentiation  
We wanted to further investigate the role of CAT7 in a biological system where both Mnx1 and 
PcG proteins are essential.  Mnx1 is expressed early in development as well as in adult tissue 21, 
and is causal of the developmental disorder Curriano syndrome 22.  Specifically, Mnx1 is essential 
for both motor neuron development and insulin-producing beta-cell formation in the pancreas.  
Interestingly, genomic analysis reveals that neuronal and beta-cell transcriptomes are closely 
related, despite their different origins in early embryogeneis (endoderm versus ectoderm) 23.  The 
similar expression patterns may largely be driven by an array of essential PcG-mediated 
regulators specific for both neuronal and beta cell differentiation, including Mnx1, Isl1, Pax6 and 
Neurod1, which are silenced and H3K27me3 in most other cell types.  We therefore were 
interested in neuronal formation based on the essential roles of Mnx1 and the PcG proteins. 
While Mnx1 is initially silenced in hES cells and bound by the PcG proteins 23-25, this repression is 
alleviated over the course of differentiation.  We decided to use an Mnx1 reporter human ES line 
to probe the role of CAT7 through differentiation.  The reporter cell line contains multiple 
insertions of eGFP under the control of a 9kb murine Mnx1 promoter, and GFP expression has 
been shown previously to correspond to endogenous Mnx1 expression 26. In previous publications 
with this cell line, this protocol robustly generates GFP-positive early motor neurons after six days 
of differentiation.  Notably, CAT7 is expressed in human ES cells (Figure 26). 
We designed a knockdown-assay in order to investigate the role of CAT7 in motor neuron 
development from human embryonic stem cells (hES cells).  Similar to our assay in HeLa cells, we 
knocked down CAT7 in an ES line by electroporation with siRNAs.  After allowing the cells to 
recover overnight in ES conditions, we directed the cells toward motor neuron differentiation by 
replacing the media with media containing neural growth factors and retinoic acid.  Finally, we 
harvested cells at 72 hours and isolated the RNA for sequencing and analysis.   
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We performed the assay and saw that CAT7 knockdown derepresses Mnx1 expression in 
neuronal differentiation conditions.  After verification of the CAT7 knockdown (>71.3% in each 
replicate) by RT-qPCR, we tested for Mnx1 expression relative to GAPDH in neurons (Figure 40).   
As seen in HeLa cells, Mnx1 was upregulated 2.3 fold and 2.7 fold in biological replicates 
relative to scrambles.   qPCR of eGFP revealed that GFP was expressed specifically in the 
knockdown cells, but at very low levels (data not shown). 
Notably, CAT7-mediated overexpression of Mnx1 was only observed in specific conditions.  
When CAT7 was knocked down in ES cells and maintained in ES-cell media for 72 hours, Mnx1 
was not overexpressed relative to a scramble control, and was lowly expressed in both samples.  
Similarly, when CAT7 was knocked down and the cells were placed in random differentiation 
conditions or in identical neural differentiation conditions without retinoic acid, Mnx1 was neither 
highly expressed nor differentially regulated between the knockdown and scramble (data not 
shown).  Together, these data indicate a role for the retinoic acid pathway in CAT7 mediated 
derepression of Mnx1.  
To more broadly test the effect of the knockdown on the PcG gene network, we sequenced the 
total RNA from the CAT7 knockdown and scramble ES cells placed in neural+retinoic acid 
conditions.  Applying the same analysis as above, we searched for genes with expression 
changed relative to a scramble control.  We saw once again that PcG targets and developmental 
regulators were highly overrepresented in the list of changed genes.  As expected from the RT-
qPCRs, Mnx1 overexpression (3.5 fold upregulation) was observed, as well as downregulation of 
the inversely related Irx3 (51% decrease) (Figure 42, Figure 43, Figure 44).  Notably, eGFP did 
not have much signal, and did not show changes in expression from the knockdown to the 
scramble at low depth (data not shown).  We also saw that the neuronal master regulator Isl1 











































































































































































































































































































































































































































































































































































































































































































































































































GAB1.    Many developmental targets listed in the Molecular Signatures database as H3K27me3 
in ES cells, MLL-targets, or genes with bivalent promoters in an array of cell types were also 
differentially expressed.  However, unlike the knockdown in HeLa cells, the Trithorax group 
proteins and Jumanji-domain containing proteins were not overexpressed.  This indicates that 
Mnx1 overexpression is not a result of elevated Trithorax group protein transcription.  
Furthermore, CAT7 may be playing different roles in the context of cancer and development. 
 
Discussion: 
In our study, we investigated a list of potential PRC1-interacting lncRNAs for involvement in the 
PcG gene-regulatory network.  We knocked down candidates in HeLa cells and searched for 
widespread changes in mRNA expression of PcG targets, relative to a scramble control.  A 
striking 11 of the 17 candidates examined showed significant changes in PcG targets upon 
knockdown, 3 showed clear changes to other pathways such as metabolism and cell cycling, and 3 
had no clear effect.  In addition, the RepE region of Xist, a highly transcribed lncRNA shown 
previously to interact with PRC2, was also identified in this study, though the above assay was not 
an effective method to validate this interaction.  Taken together, these data demonstrate that the 
wide dynamic range of the protocol used to identify these interactions (Chapter 2) allows capture 
of biologically relevant lncRNAs across a wide range of expression.  Specifically, we have 
generated a technology which successfully identified multiple PRC1-interacting candidates that 
influence the PcG gene-regulatory network. 
We also showed that knockdown of one of our candidates, CAT7, not only causes overexpression 
of the PcG/Shh-regulated gene Mnx1, but also leads to loss of a PRC1 component, a PRC2 
component and H3K27me3 binding at the Mnx1 promoter.  This is consistent with Mnx1 
derepression observed in our Suz12 knockdown. During early motor neuron differentiation from 
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hES cells, knockdown of CAT7 causes significant changes in expression of several Shh/PcG 
regulated motor neuron master regulators.  Namely, upregulation of Mnx1 and Isl1, and 
downregulation of Irx3, were observed.  These factors are initially repressed with H3K27me3 
signatures in the ES-cell state and are activated during differentiation.  Although CAT7 is 
expressed in hES cells, knockdown of the transcript does not result in upregulation of Mnx1 in the 
absence of differentiation.  Similarly, identical neural differentiation conditions which lack retinoic 
acid show low, non-differential Mnx1 expression between candidates. This indicates that 
knockdown of CAT7 is not sufficient to initiate derepression of Mnx1, and might require additional 
components from the retinoic acid pathway. 
Furthermore, while CAT7 depletion induced upregulation of activation factors such as the 
Trithorax group proteins and Jumanji domain containing proteins, in HeLa cells, none of these 
factors were upregulated as an effect of CAT7 depletion in differentiating motor neurons.  This 
could represent the different effects of CAT7 in different cellular contexts. 
The widespread transcriptional effects seen in this study evoke a mechanistic question of how 
lower abundance lncRNAs could elicit broad responses in PcG networks. We can further address 
this question by examination of one of our candidates that influences the PcG gene network.  This 
candidate shares an exon with the previously studied transcript DA125942.  During 
chondrogenesis, DA125942 plays an important role in expression of master developmental 
regulators 12.  Namely, complementary to our findings, prior network analysis suggested that 
overexpression of DA125942 enacts a negative feedback loop leading to decreased PTHLH 
(chondrogenic developmental regulator) expression (cis) and decreased SOX9 (developmental 
gene) expression (trans).  This leads to widespread changes in both EZH2 binding and gene 
expression of a variety of PcG targets. Though PTHLH and SOX9 are not expressed in our HeLa 
cells, the isoform of DA125945 found in HeLa cells may be influencing another developmental 
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regulator or perhaps may play tissue-specific developmental roles, based on the nuclear 
landscape.  
DA125942 is transcribed from a regulatory locus, CISTR-ACT which is located in close physical 
(3D) proximity to PTHLH and Sox9 (in trans) during chondrogenesis. In certain forms of 
Brachydactyly, D125942 is upregulated, PTHLH is translocated far away from the CISTR-
ACT/SOX9 locus and has reduced expression, and SOX9 expression is also reduced. Our study 
additionally suggests an interaction between an isoform of DA125942 with the PcG proteins in 
HeLa cells, where the 3D contacts of CISTR-ACT has not been investigated.  Collectively, these 
data could support a model where lncRNAs interact with the chromatin factors, such as the PcG 
proteins, to repress even trans targets that are in close physical proximity, and initiate a 
widespread signaling cascade.  Such a model is consistent with previous reports of PcG proteins 
affecting co-localized, co-regulated regions of the chromatin (such as PcG bodies). It is also 
consistent with reports of various lncRNAs, such as Xist 5,27, Kcnq1ot1 28,29, and HOTTIP 30, which 
affect chromatin architecture and expression in close physical proximity to the RNA.  
Broad application of this model can also explain how low-abundance nuclear lncRNAs reach 
distal targets to affect large genomic networks.  Explicitly, low-expression lncRNAs could influence 
multiple targets by working at co-localized regions, such as in PcG bodies, to enact a signaling 
cascade.  Expanding this model, we note that the PcG proteins are proposed to scan the genome 
for their targets, perhaps through an EZH2/RNA interaction.  While surveying the chromatin, the 
PcG proteins might bind specific lncRNAs at their transcription sites, and then use the lncRNA to 
properly target the complex.  Such a mechanism could serve to physically bring target lncRNAs to 
particular PcG regulated sites in both cis or trans, and in some instances might bypass the 
constraint that a low-expression lncRNA be transcribed in precisely the same 3D-space as its 
target gene. 
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Extending this model to CAT7, we see that CAT7 and Mnx1 are located 400kb away from each 
other near the borders of adjacent PcG-rich gene desert regions.  While CAT7 mediated 
recruitment of the PcG proteins to the Mnx1 promoter is perhaps the simplest mechanistic 
explanation for the interaction and derepression observed in this study, such we cannot verify that 
CAT7 is localized to the Mnx1 promoter.  Technologies such as RNA/DNA-FISH, CHART, or RAP 
could be used to map the RNA to a distinct locus or loci on the chromatin, though these methods 
are not yet optimized for low abundance transcripts.  Such studies could also be supplemented 
with DNA/DNA-FISH or 3C to gauge physical proximity of CAT7 and Mnx1.  
 
Conclusion 
In our screen, we sought to validate the relevance of our candidates from Chapter 1 to the PcG 
gene-regulatory network.  We found that the majority (11/17) of candidates tested did, in fact, 
yield widespread changes to PcG target-gene expression upon siRNA knockdown.  Furthermore, 
perturbation of one candidate, CAT7, causes overexpression of the nearby master developmental 
protein Mnx1, and the Mnx1 promoter loses a significant portion of PcG binding.  These results 
also validated in early motor neurons differentiating from ES cells, where siRNA depletion of 
CAT7 caused misregulation of essential motor-neuron regulators.  Taken together, our results show 
that the protocol we have developed in Chapter 1 identifies a class of lncRNAs which impact PcG 
recruitment, and gene-expression of PcG targets. 
 
Methods: 
HeLa Cell Culture 
HeLa cells stably transduced with a copy of FLAG- tagged Bmi1 at approximately 25% 
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overexpression11 were cultured in DMEM supplemented with 10% FBS (Sigma), NaHCO3 pH 7.5 
and gentamycin.   Cells were grown in suspension in a spinner flask (Matrical) to a density of 
approximately 3x108 cells per liter. 
 
Human ES cell culture and differentiation to motor neurons 
Human embryonic stem cells (hESCs) were maintained on plates coated with hESC-qualified 
Matrigel (BD Biosciences) in chemically defined mTeSR-1 medium (Stemcell technologies) and were 
passaged by manual picking or enzymatic digestion with TrypLE Express (Life Technologies) in the 
presence of 10 µM Y27632 (Sigma). For all experiments, passage number was less than 40. 
Media was changed daily. 
hESCs were differentiated using a differentiation basal media containing 1:1 DMEM/F12 (Life 
Technologies) and NeuroBasal (Life Technologies), 2 mM glutamax-I (Life Technologies), 1x N2 
supplement (Life Technologies), 1x B27 supplement (Life Technologies). For the non-directed 
differentiation, basal media was supplemented with 10% fetal calf serum (FCS) (Life 
Technologies).  For neural differentiation, the media was supplemented with 10nM SB431542 
(Sigma), 1 μM dorsomorphin (Millipore) and for certain experiments additionally with 0.1 μM 
retinoic acid (RA) (Sigma). Media was changed daily. 
 
siRNA Knockdown 
siRNAs were ordered from BioSciences.  For HeLa cells, 106 cells were nucleofected in 100uL of 
Nucloefector R solution and 200nmoles of siRNA.  Nucleofections were carried out using program 
I-013 on the Nucleofector II as per manufacturer’s instructions.   After 48 hours, cells were isolated 
for RNAseq or ChIP.  For ES cells, the Neon torrent was used in place of the Nucleofector II.  
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2x106 cells were used in 1 pulse, 1200V, 20ms.  All siRNA sequences can be found in 
Supplemental Table 2. 
 
RNA purification, cDNA generation, and preparation for libraries for RNAseq 
Whole cells, nuclei, or cytosolic were stored in Trizol (Invitrogen).  Chloroform was added and the 
sample was spun out according to the manufacturer’s instructions.  The aqueous phase was 
applied to Zymo Clean-and concentrator 5 columns and DNAse was applied “in tube”as per the 
manufacturer’s instructions for RNAs larger than 200 nucleotides.  For RT-qPCR, cDNA was 
generated using SUPERscript VILO (Invitrogen).  For sequencing, isolated RNA was ribo-depleted 
using the Ribo-Zero Magnetic Gold kit (Epicentre/Illumina) according to manufacturer instructions, 




Samples were dissociated from wells and pooled, and an aliquot of cells was reserved for RNA 
isolation (to test knockdown).  ChIP was performed on the remaining cells, as previously published, 
but at a smaller scale24,25.  Briefly, 5x106 cells were crosslinked with 1% HCHO for 10 minutes in 
media, at room temperature. Bmi1 antisera31, Suz12 (ab12703), H3K27me3 (ab6002), or rabbit 
IgG (Jackson Labs) was prebound to 20uL ProteinA beads in BSA (with 2ug Ab), and then added 
to sheared nuclear lysate from the crosslinked cells.  Beads were washed in RIPA buffer four times 
and chromatin was eluted in Tris, SDS, and EDTA at 65C.  After crosslink reversal, RNAse 
treatment, Proteinase K treatment and phenol-chloroform isolation, DNA was EtOH precipitated 




qPCR was performed as per manufacturer’s instructions using the Biorad iTaq 2X master mix). 
Primer sets can be found in Supplemental Table 1. For RT-qPCR, approximately 2ng cDNA/well 
was used. 
 
Native Cell Fractionation 
Nuclear isolation was performed in native cells, as previously published32,33 and checked by 
hemocytomter (>97%) with Trypan blue.  Cytosolic extract was also reserved, alongside whole 
cell extract.  All extracts were immediately stored in Trizol. 
 
Northern Blot and RACE Analysis 
Nuclei were isolated from native cells to >97% purity by Trypan Blue staining on a 
hemocytometer.  Northern blot analysis was performed using RNA probes as in previously 
published protocols34, with the exception that a Hybond-N+ membrane was used instead of 
nitrocellulose.  RACE was performed using the Ambion RLM-RACE kit (AM1700) as per 
manuafacturer’s instructions.   






Gene Set Enrichment 
RNAseq data was aligned to the hg19 build of the genome.  Only uniquely mapped, non-
duplicated reads were included.  This yielded an average of 15M reads per lane.  Samples were 
normalized by total reads, and total reads mapping back to an mRNA (only at exonic regions, as 
defined by RefSeq15) were compared in a scramble control versus an individual knockdown.  
Removing any mRNA that had fewer than 5 reads in either lane, we then searched for mRNAs 
that showed greater than 2-fold difference between a sample and the scramble control.  This 
analysis included multiple isoforms.  However, after identifying differentially expressed genes, we 
only considered one isoform per differentially expressed gene, to avoid bias.  We entered 
differentially expressed genes into the Molecular Signatures Database16 and compared our gene 
set to 6,791 others (default parameters, but excluding cancer gene sets and TF binding site 
motifs).  We then identified if Suz12, PRC1, or H3K27me3 related gene-sets were significantly 
enriched using a broad null hypothesis (that all genes in the Molecular Signatures Database were 
expressed above background).  We then calculated true p-values for the enrichment of these sets 
by considering the total number of genes actually expressed above background (as before) in 
the cell, which were also identified in the Molecular signatures database.  We used a 
hypergeometric distribution to generate p-values and (rounded) expected values.  A summary of 
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AND FUTURE DIRECTIONS  
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In our study, we developed a general protocol to identify lncRNAs that interact with chromatin 
proteins (CATs). By applying this protocol to Bmi1 of PRC1, we identified at least 11 novel 
candidates whose expression impacts PcG binding and/or PcG target gene expression.  One such 
lncRNA, CAT7, also influences transcription of key neuronal factors during early motor-neuron 
differentiation from human embryonic stem cells. 
Our final efforts in the lab will be to further characterize CAT7 and a few other lncRNAs.  We 
have generated libraries from the PcG ChIP-qPCR in CAT7 knockdowns from Chapter 2. In this 
way, we can look genome-wide for the effects of knockdown on PcG recruitment.  Similarly, we 
have knocked down 2 more CAT’s and are awaiting ChIP sequencing. We will also compare our 
results with HiC data to look for co-localization of affected genes and the lncRNA transcription 
site. 
Interestingly, CAT7 is conserved by sequence in Zebrafish.  Preliminary of results show that CAT7-
targeted morpholino leads to a sinusoidal back defect in developing zebrafish.  Experiments to 
try to rescue the phenotype with the human RNA are underway.  In addition, we want to gauge 
the impact of Rep E deletion in mouse or human, on PRC1 recruitment to the inactive X by IF.  This 
experiment will be done either by LNA-knockoff + IF, or by IF in deletion mutants. 
Finally, others in the lab may try to optimize CHART or RAP to look at where on the chromatin the 
CATs are binding.  As of yet, these technologies have only worked for very highly abundant 
lncRNAs, so the feasibility of these protocols on low abundance transcripts is yet unclear.   The lab 
may also use this protocol to look at interactions with other chromatin proteins as well.  It is with 
humility and great pleasure that I see my work continuing in others’ hands and I look forward to 
seeing how it evolves.   
Thank you for your time and attention. 
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